WO2019009663A1 - Composition for preventing and ameliorating athlete's foot - Google Patents

Composition for preventing and ameliorating athlete's foot Download PDF

Info

Publication number
WO2019009663A1
WO2019009663A1 PCT/KR2018/007695 KR2018007695W WO2019009663A1 WO 2019009663 A1 WO2019009663 A1 WO 2019009663A1 KR 2018007695 W KR2018007695 W KR 2018007695W WO 2019009663 A1 WO2019009663 A1 WO 2019009663A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
composition
extract
athlete
foot
Prior art date
Application number
PCT/KR2018/007695
Other languages
French (fr)
Korean (ko)
Inventor
최병규
Original Assignee
최병규
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 최병규 filed Critical 최병규
Publication of WO2019009663A1 publication Critical patent/WO2019009663A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/14Cupressaceae (Cypress family), e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238Saposhnikovia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Definitions

  • the present invention relates to a composition for prevention and improvement of athlete's foot. More particularly, the present invention relates to a cosmetic or an external-use composition for prevention and improvement of athlete's foot having skin protection, antioxidant and antimicrobial action simultaneously with natural oil as a main ingredient.
  • the hormone abnormality due to excessive stress in modern society and sudden changes in the external environment may cause the abnormal keratinization of the stratum corneum to fall off due to atmospheric pollutants or ultraviolet rays, The skin tone becomes unstable and the skin becomes rough and dull.
  • Skin aging is caused by oxidative damage of intracellular substances by free radicals. That is, highly reactive free radicals, such as active radicals such as hydroxy radicals and superoxide radicals, oxidize the lipid components constituting the cell membrane to destroy the cell membrane, thereby oxidizing the protein and stopping the function of the nucleic acid, It destroys its components and causes cell death.
  • free radicals such as active radicals such as hydroxy radicals and superoxide radicals
  • Antioxidant cosmetics By inhibiting oxidative damage in vivo, aging of the skin can be prevented or reduced.
  • Antioxidant cosmetics inhibit the oxidative damage of skin, including the oxidation of fat components, to prevent or delay skin aging.
  • the production amount and the market growth rate of a multi-functional cosmetic having two or more functionalities are much higher than those of a single functional cosmetic product.
  • Korean Patent Registration No. 10-1117564 discloses that excessive salt and / or sugar; Water phase component; Anionic, amphoteric and nonionic surfactants; And a polyol, wherein the salt is supersaturated and dissolved in the cosmetic composition, and the supersaturated and dissolved salt is present in the form of recrystallized particles, the water component is purified water, and the anionic surfactant is ammonium laureth sulfate ,
  • the amphoteric surfactant is cocamidopropyl betaine, the nonionic surfactant is cocamide di-is, and the polyol is glycerin.
  • the patent is based on the finding that the patent is capable of obtaining exfoliation, skin amelioration, blood circulation promoting effect and formulation safety by recrystallized salt and / or sugar particles and of remaining in a saturated solution of salt and / Salt and / or sugar exhibits a moisturizing function. It contains anionic, amphoteric and nonionic surfactant, and is excellent in skin cleansing effect and rinsability. Also, it is excellent in ease of use in the form of a gel.
  • the function of the normal cells due to the sterilization action peculiar to the salt is deteriorated and the collagen is destroyed thereby causing excessive aging of the skin.
  • the inventors of the present invention have made intensive studies to develop a cosmetic or composition for prevention and improvement of athlete's foot which has skin protection, antioxidant and antimicrobial action simultaneously with natural products, and as a result, Of course, it has been confirmed that it has an antioxidative and antimicrobial action and completed the present invention.
  • a flavor enhancer which comprises 50 to 75% by weight of tea tree oil, 10 to 30% by weight of avocado oil, 3 to 15% Athlete's foot (50%), vitamin E acetate (0.5 to 2 wt%), polysorbate (20) 0.5 to 2 wt%, benzyl alcohol 0.01 to 0.05 wt% and thymol 0.01 to 0.05 wt% Or an external composition for improvement.
  • composition for prevention or improvement of athlete's foot is a cosmetic or pharmaceutical composition for prevention and improvement of athlete's foot since the composition for preventing or improving athlete's foot is natural oil as a main ingredient and exhibits skin protection, antioxidant and antibacterial action simultaneously as well as less side effects such as toxicity and skin irritation Can be preferably used.
  • Figure 1 is a graph showing DPPH free radical scavenging performance of the example compositions.
  • the present invention provides a method for producing an extract, comprising, in one aspect, 50 to 75 wt% of tea tree oil, 10 to 30 wt% of avocado oil, 3 to 15 wt% of windshield extract or cottonwood extract, 3 to 15 wt%
  • a thickening agent for athlete's foot comprising 0.5 to 2% by weight of vitamin E acetate, 0.5 to 2% by weight of vitamin E acetate, 0.5 to 2% by weight of polysorbate 20, 0.01 to 0.05% by weight of benzyl alcohol and 0.01 to 0.05% Prevention or amelioration.
  • Tea Tree Oil one of the main components of the composition of the present invention, is a plant native to Australia and belongs to the genus Myrtaceae. It contains particulate matter in the leaves. When the leaves are crushed, Lt; / RTI > is obtained.
  • the tea trioyl contained 2.5% of alpha-pinene, 9.1% of alpha-terpinene, 3.9% of para-cymene, 4.3% of 1.8-cineol, 24.6% of gamma-terpinene, 2.3% of alpha-terpineol, 42.1%, terpinolene 4.1%, and trace amounts of residual components.
  • the effect of antibacterial as well as antiinflammatory, analgesic and wound treatments is effective. Its action mechanism is not clear as its effect is similar to that of ginseng.
  • tea tree oil is preferably compressed or rectified using leaves.
  • avocado oil is a vegetable oil made by squeezing flesh and skin.
  • avocado is rich in vitamin E called tocopherol, which is one kind of fat-soluble vitamin. It removes active oxygen from our body and suppresses aging. And is known to have the effect of preventing heart disease and cancer.
  • the avocado oil is preferably used by pressing or rectifying the flesh of the flesh.
  • the windshield (Saposhnikoviae divaricata Schiskin) is a perennial herb that belongs to the mountain-type Umbelliferae (Umbelliferae) and is a perennial herb called jinhwa wind, mountain wind wind, screen wind herb, mountain windbreak tree, It is widely distributed in Korea, China, Vietnam and Mongolia. It is known that the main effects of windblown by oriental medicine are sweating, fever, analgesic, diuretic, paralysis, limb paralysis, shinhae, geumdam, toothache, neuralgia, rheumatism and so on.
  • Chamaecyparis obtusa (Chamaecyparis obtusa) is an evergreen arborescent tree, and it is also called ashiko, hinoki and cypress. It is 30 ⁇ 40m in height and 1 ⁇ 2m in width.
  • the bark is reddish brown, and small needle-shaped leaves are densely grown on branches. It is distributed in Japan and southern part of Korea. It contains ⁇ -cadinene, ⁇ -terpineol and borneol, and leaves and wood contain 1% essential oil. . It is used as a natural insecticide for the prevention of house dust mites causing allergic diseases such as atopy, asthma and rhinitis. It is recommended to use the leaves, stems, and branches extracted from the leek.
  • the windshield and the leathery extract may be used singly or in the form of a mixture.
  • Rhizoma Polygoni Cuspidati is a plant belonging to the family Polygonaceae and grows in mountainous areas and is distributed in Korea, Japan, Taiwan and China. In one room, the roots are called hojanggun, and they are used as relaxation, diuretic, and tongue economy, and as a sedative in the private sector. When it is young, the stem looks like a hoof, and it has the name Ho Chang Geun. Root can be obtained by extracting roots and rootstocks.
  • Sasae is a plant of various ages of paddy field and grows frequently in the southern part of Korea and the mountains of Jeju Island.
  • the stem is straight up to 1 ⁇ 2m in height, 3 ⁇ 6mm in diameter, and the bract covers the stem for 2 ⁇ 3 years.
  • the nodes are covered with inverted hair and white powder, but the leaves of the sheath-shaped leaves disappear after 4 years.
  • Leaves are long, oval-shaped, 10 ⁇ 25cm long, pointed like a tail or long as the tail. There are no hairs on both sides of the leaf, there are hairs on the base of the back side, there are saw teeth like thorn on the edge, and the sheath has hairs. It is known to reduce fever and poison, remove sputum, urinate well, and smooth metabolism. Sasa can be obtained by extracting leaves, stems and roots.
  • the vegetable oil containing the tea tree oil and the avocado oil may be obtained by squeezing a leaf, a fruit or a fruit into plants or by adding an extraction solvent to the raw material at a weight ratio of 1: 2 to 1:20, and adding the extract to a reflux condenser After cooling by heating distillation for 2 to 3 hours, the extracted extract can be separately filtered for 5-7 hours.
  • the crude oil may be purchased commercially and used.
  • Leaves, stems, branches and the like can be extracted by hot water extraction, cold-watering or warm-up extraction.
  • the extraction solvent is mixed with the extraction solvent at a weight ratio of 2 to 20 times, and the mixture is extracted at 70 to 125 ° C for 2 to 24 hours, filtered and concentrated to obtain an extract
  • the bamboo shoots, bamboo shoots, and windshield roots are thoroughly cleaned, dried, and then added with an extraction solvent 5 to 10 times the weight of the raw materials.
  • the resulting mixture is placed in a autoclave autoclave and heated at 65 to 125 ° C for 2 to 6 hours, Extraction by heating for 5 hours, filtration and concentration may be obtained
  • the extraction solvent may be at least one selected from water, lower alcohols having 1 to 4 carbon atoms, polyhydric alcohols, and mixtures thereof.
  • the lower alcohol having 1 to 4 carbon atoms methanol, ethanol and the like can be used.
  • the polyhydric alcohol butylene glycol, propylene glycol, pentylene glycol and the like can be used. Mixtures of water and lower alcohols, mixtures of water and polyhydric alcohols, mixtures of lower alcohols and polyhydric alcohols, or mixtures of water and lower alcohols and polyhydric alcohols can be used as the mixture.
  • the present invention is mainly characterized in finding ingredients having multifunctional properties such as skin protection, antioxidant activity and antibacterial property from natural plants and an optimal combination ratio thereof.
  • the tea tree oil, avocado oil, Extracts and vitamin E acetates are the main components of skin protection, antioxidant, and antibacterial activity.
  • Sasa extract acts as a preservative.
  • Polysorbate acts as a dispersant.
  • Benzyl alcohol and thymol act as preservatives and stabilizers. do.
  • composition ratio of the composition according to the present invention is set considering the effective dose and side effects of each component, and if the ratio is out of the range, the effect may be deteriorated.
  • the desired effects of the present invention can be achieved by mixing the above-mentioned natural plant extracts at an optimum ratio, thereby preventing growth of various microorganisms and maximizing cell protection and antioxidative effects.
  • the antibacterial effect is insufficient.
  • the amount of the tea trioyl is more than 75 wt%, the effect of increasing the amount of the tea trioyl is insufficient.
  • the antioxidative and preservative effect of avocado oil is less than 10% by weight, and when it is more than 30% by weight, the synergistic effect by combination with each ingredient may not be achieved.
  • the skin protection, antioxidant and germicidal effect are less than 3% by weight of the roots extract or the cotton bud extract and the silkworm extract, and less than 15% by weight are uneconomical because the composition is not balanced with the whole composition.
  • the content of the sage extract is 1 to 10% by weight, the content of vitamin E acetate is 0.5 to 2% by weight, the content of polysorbate 20 is 0.5 to 2% by weight, the content of benzyl alcohol is 0.01 to 0.05% by weight and the content of thymol is 0.01 to 0.05% %, It is possible to optimally exhibit stable coordination and various functions of the entire composition.
  • composition according to the present invention contains an extract of a natural substance, which is not a chemical synthesis agent, it can be seen from the results of Examples and Test Examples described later that there is no irritation or toxicity to the skin and thus it is excellent in stability. But also can be used as a cosmetic or therapeutic agent requiring such functionality since it has antimicrobial activity against bacteria including aceotrophic bacteria, healing of atopic dermatitis, therapeutic treatment of infant's dirt, protection against skin and improvement of skin texture have.
  • the present invention provides, in a further aspect, a composition for improving athlete's foot comprising the composition and cosmetics or a pharmaceutically acceptable carrier as an active ingredient.
  • the formulations of the cosmetics may be prepared by conventional methods well known in the art of cosmetics.
  • excipients of these cosmetics may vary depending on the purpose of use, but they generally contain a preservative such as glycerin, butylene glycol or propylene glycol or a vegetable preservative, a purified water, a moisturizer, a bulking agent, a cream agent, a surfactant, a pH adjuster, It is preferable to mix them according to the form of the desired formulation.
  • a preservative such as glycerin, butylene glycol or propylene glycol or a vegetable preservative
  • a purified water a moisturizer, a bulking agent, a cream agent, a surfactant, a pH adjuster, It is preferable to mix them according to the form of the desired formulation.
  • composition of the present invention can be suitably formulated in the form of an external preparation such as a suspension, emulsion or aerosol according to a conventional method.
  • composition of the present invention is prepared from a pharmaceutical composition, it may be preferable to further include a conventional pharmaceutically acceptable carrier.
  • the dosage of the pharmaceutical composition of the present invention is suitably set in accordance with the form of the preparation, the method of administration, the purpose of use, and the age, body weight, and symptoms of the patient to which the active ingredient is administered. For example, 10 mu g to 200 mg / kg per day for an adult.
  • the pharmacokinetic properties of a particular reagent and its mode and route of administration Age, health, weight; It will be understood that the dosage varies depending on known factors such as the nature and extent of the symptoms, the type of concurrent treatment, the frequency of treatment and the desired effect.
  • Each of the components obtained in Examples 1 to 3 was formulated in a formulation ratio shown in Table 1 below to prepare a composition for preventing athlete's foot.
  • Each plant oil and extract was mixed with purified water extract and alcohol extract at a weight ratio of 1: 1.
  • Example 4 Example 5
  • Example 6 Example 7
  • Example 8 Comparative Example Tea trio day 50 55 53 65 70 70
  • Avocado oil 10 30 10 10 20
  • 1.0 - Vitamin E-acetate 0.94 0.94 0.50 2.0 1.0 - Polysorbate (20) 2.0 0.50 0.90 0.9 0.9 - Benzyl alcohol 0.01 0.05 0.05 0.05 0.05 - Thymol 0.05 0.01 0.05 0.05 0.05 - Sum 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100 100
  • Test Example 1 Antioxidative effect analysis of natural extract composition
  • the in vitro antioxidant activity was measured by reacting the free radical DPPH having the maximum absorbance at 517 nm with the compositions of Examples 4 to 8 to determine the antioxidative effect using the absorbance value lowering in yellow.
  • DPPH free radical scavenging activity was determined using a reaction mixture comprising the composition of the example dissolved in methanol in a 96-well microplate and 0.1 mM DPPH dissolved in ethanol. The extracts were mixed with 0.6 mL of DPPH solution and incubated at room temperature for 20 minutes. The absorbance of the reaction mixture was then measured at 517 nm. The percent inhibition of radical scavenging was determined in comparison to the ethanol treated group or the ascorbic acid (100 [mu] g) treated group. The percentage of DPPH free radical scavenging activity was calculated by the following equation.
  • Figure 1 is a graph showing DPPH free radical scavenging performance of the example compositions.
  • Con vehicle treated group as a negative control group
  • AA treated with ascorbic acid (1 mg / ml) as a positive control group
  • Sample of 100 ⁇ sample (hereinafter, the same as in the test example).
  • Hydroxyl radical scavenging activity was measured by reacting hydroxyl radicals generated by Fenton ' s reagent with the composition of the examples to lower the absorbance value.
  • Embodiment the composition 100 ⁇ M EDTA, it was added to the reaction mixture containing oxy-ribose 1 mM H 2 O 2, and 2.8 mM to. The volume was supplemented with 20 mM pH 7.4 phosphate buffer to make 1 mL and then incubated at 37 ° C for 1 hour.
  • FIG. 2 is a graph showing the hydroxy radical scavenging activity of the example composition.
  • Positive control ascorbic acid (AA) inhibited free radicals by 51.69 ⁇ 1.13% at 1 mg / ml concentration.
  • the results are shown in Table 1.
  • the sample treatment groups were 41.25 ⁇ 0.67 (Example 4), 42.75 ⁇ 0.76 (Example 5), 47.87 ⁇ 0.83 (Example 6), 45.21 ⁇ 0.96 (Example 7), 39.01 ⁇ 0.89 23.50 ⁇ 1.23 (comparative) (FIG. 2).
  • compositions of the examples were mixed with 100 ⁇ L of Folin-Denis reagent and incubated for 3 minutes at room temperature (RT, 22-24 ° C.)
  • the reaction mixture was neutralized with 100 ⁇ l of 10% sodium carbonate and incubated for 1 hour.
  • Absorbance was measured at 760 nm with a plate reader. Polyphenol content was calculated using gallic acid as standard.
  • Example 4 Example 5
  • Example 6 Example 7
  • Example 8 Comparative Example Polyphenol (mg / g) 56.72 + 1.51 57.32 + - 0.98 52.77 + - 0.54 56.45 + 0.71 52.34 + - 0.35 25.43 + - 0.23
  • Flavonoid (mg / g) 7.41 ⁇ 0.82 8.55 0.35 8.01 + - 0.78 8.25 + - 0.66 7.15 ⁇ 0.78 2.16 ⁇ 0.35
  • Reducing power efficacy analysis was based on the comparison of the effect of ascorbic acid with the lowering of the absorbance value by reacting the composition of each Example with the induction of oxidative reaction by FeCl 3 .
  • compositions of the examples were mixed with 0.5 mL of 200 mM sodium phosphate buffer (pH 6.6), and 0.5 mL of 1% potassium ferricyanide, then the mixture was incubated at 50 DEG C for 20 minutes, followed by 0.5 mL of 10% TCA . It was centrifuged at 650 g for 10 minutes and 1 mL of supernatant was mixed with equal volume of distilled water and 0.2 mL of 0.1% ferric chloride. The same treatment was performed on standard ascorbic acid solution and the absorbance was measured at 700 nm. The reducing power was calculated and expressed in terms of ascorbic acid.
  • Example 4 Example 5
  • Example 6 Example 7
  • Example 8 Comparative Example The ascorbic acid equivalent (g) 28.12 ⁇ 1.51 27.23 + - 0.31 22.67 ⁇ 0.51 26.35 ⁇ 0.78 22.36 + - 0.92 13.34 ⁇ 0.53
  • the activity of Fe 2+ chelating activity was measured by reacting the composition of the present invention with the induction of the oxidative reaction by the Fe 2+ -ferrozine complex to lower the absorbance value.
  • Fe 2+ chelating ability (%) (Abs control without sample - Abs sample ) / Abs control without sample ⁇ 100.
  • the negative control group was treated with vehicle (Tris-HCl buffer) and the positive control group was treated with ascorbic acid to analyze Fe 2+ chelating activity.
  • FIG. 3 is a graph showing the results of Fe 2+ chelating assay analysis of the composition of the examples.
  • Positive control ascorbic acid (AA) inhibited the oxidative response of Fe 2+ -ferrozine complex by 39.08 ⁇ 3.92% at 1 mg / ml concentration.
  • the compositions of each example inhibited the oxidative response of the Fe 2+ -ferrozine complex by 46.21 ⁇ 1.02% to 53.25 ⁇ 2.02% at 100 ⁇ l, while suppressing the comparative example by 18.51 ⁇ 1.85%.
  • nitrite scavenging activity was measured by comparing the absorbance of the nitrite with the composition of the examples to determine the antioxidative effect.
  • vehicle (PBS) was treated with negative control group and nitrite scavenging ability was treated with ascorbic acid in positive control group.
  • Each sample was treated with 0.1 N HCl solution (pH 1.2), pH 3.0 and pH 5.0 solution, and 1 mM NaNO 2 solution was added. The mixture was incubated at 37 [deg.] C for 1 hour. 2% acetic acid and Griess reagent were added and incubated at room temperature for 15 minutes. The absorbance of the mixture was measured at 520 nm.
  • Nitrite inhibition (%) [1 - (Abs sample / Abs control without sample )] x 100.
  • Control group treated with PBS as a negative control group
  • AA a group treated with ascorbic acid (1 mg / ml) as a positive control
  • 100 ⁇ g 100 ⁇ g of a composition as a sample group.
  • Positive control ascorbic acid (AA) inhibited nitrite at a concentration of 1 mg / ml by 91.0 ⁇ 3.12% at pH 1.2.
  • the composition of each example inhibited nitrite at 56.73 ⁇ 1.12% (Example 4) to 61.32 ⁇ 1.09% (Example 7) at pH 1.2 and 20.51 ⁇ 0.76% inhibition of the comparative example.
  • compositions according to Examples 4 to 8 were tested by disc paper test.
  • test strain was dispensed into a petri dish, spread over the entire medium using a glass rod, and then placed on a paper disc having a diameter of 5 mm. Then, 30 ⁇ l of the composition of each example was placed on a paper disc. After overnight incubation at 30 ° C, the inhibition zone was checked for antimicrobial activity. The results are shown in Table 4 below.
  • the composition according to the present invention has excellent antimicrobial activity against bacteria such as fungi such as aphthous fungus, though it has a difference in degree. Therefore, it can be used as a cosmetic product or a treatment for athlete's foot.
  • Test Example 3 Measurement of growth inhibitory activity of fungi
  • the size of the growth inhibition ring by the composition of the examples was 2.5 cm or more and showed excellent fungicidal activity. These antimicrobial activities were similar in other fungi.
  • Skin irritation experiments were conducted to examine the degree of irritation of each composition according to the present invention to experimental animals.
  • Eighteen New Zealand white rabbits weighing 2.3 to 2.7 kg were used as experimental animals.
  • experimental animals were refined in an animal room for one week after their intake, and normal animals were observed during the refinement period and only healthy animals were used for the test.
  • the rabbits were divided into treatment compartments and control compartments 24 hours before application of the test substance, and then 0.5 ml of the test substance per test animal was applied once to the administration site, and sterilized physiological saline was applied to the untreated control compartment in the same amount . After attaching, it was covered with a sheet of solid material, fixed with a tape, and applied for a certain period of time.
  • the application portion was gently rinsed with physiological saline.
  • local anesthetics lidocaine, Gwangmyeong drug
  • lidocaine, Gwangmyeong drug were injected through the ear vein and euthanized, followed by autopsy. And observed with naked eyes.
  • compositions of the examples were subjected to acute toxicity studies and their toxicity was observed.
  • male and female SD rats of 105 weight and 105 weight, respectively were used and tested by using the compositions of the respective examples and distilled water as a negative control.
  • the rats were incubated in a laboratory incubation box with a temperature of 22 ° C, a relative humidity of 53% and a fluorescent light (09:00 lit-18: 00 off) contrast cycle and a light intensity of 150-300 Lux for about a week , And then healthy animals were selected and divided into groups so that the average body weight was matched.
  • the animals were orally administered at a dose of 20 ml / kg once a day for 14 days, and then the changes in general condition, poisoning symptoms, , Autonomic nerves, weight change, and presence of dead animals.
  • the present invention relates to a cosmetic or pharmaceutical composition for prevention and improvement of athlete's foot since the composition for prevention or improvement of athlete's foot is natural oil as a main component and exhibits skin protection, antioxidant and antimicrobial action simultaneously as well as less side effects such as toxicity and skin irritation It is useful in the production of related products.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a composition for preventing and ameliorating athlete's foot. More specifically, the present invention relates to a cosmetic or pharmaceutical composition for preventing and ameliorating athlete's foot, which has skin protection, antioxidant and antimicrobial activity simultaneously by comprising a natural oil as a main ingredient. Since the composition for preventing or ameliorating athlete's foot according to the present invention comprises a natural oil as a main ingredient, and thus has few side effects such as toxicity and skin irritation and exhibits skin protection, antioxidant and antibacterial activity at the same time, said composition can be preferably used as a cosmetic or pharmaceutical composition for prevention and improvement of athlete's foot.

Description

무좀 예방 및 개선용 조성물Composition for prevention and improvement of athlete's foot
본 발명은 무좀 예방 및 개선용 조성물에 관한 것으로서, 좀 더 상세하게는 천연 오일을 주성분으로 하여 피부보호, 항산화 및 항균 작용을 동시에 갖는 무좀 예방 및 개선용 화장품 또는 외용제 조성물에 관한 것이다.The present invention relates to a composition for prevention and improvement of athlete's foot. More particularly, the present invention relates to a cosmetic or an external-use composition for prevention and improvement of athlete's foot having skin protection, antioxidant and antimicrobial action simultaneously with natural oil as a main ingredient.
피부과학을 통한 생리적 메커니즘에 대한 연구 및 효능은 한 계 높은 새로운 소재로서 천연물로부터 유효성분을 추출 정제하는 연구로부터, 단순히 피부보호 차원에서 머물던 화장품이 그 효능에 있어서 피부개선의 범주까지 확대된 기능성 화장품에 대한 수요가 급증하고 있다.The study and efficacy of physiological mechanism through dermatological science has been studied from extracting and purifying the active ingredient from natural materials as a new high material, from the study of merely staying in the dimension of skin protection, There is a surge in demand for.
현대 사회의 과도한 스트레스로 인한 호르몬의 이상과 급작스런 외부 환경의 변화로 인하여 피부의 방어 기제를 능가하는 대기 오염 물질이나 자외선 등의 영향으로 각질층의 각질이 정상적인 주기로 떨어져 나가지 못하거나 혹은 떨어져 나가는 주기의 불균형으로 인하여 피부 톤이 일정치 않게 되어 피부가 거칠고, 칙칙해 보이게된다.The hormone abnormality due to excessive stress in modern society and sudden changes in the external environment may cause the abnormal keratinization of the stratum corneum to fall off due to atmospheric pollutants or ultraviolet rays, The skin tone becomes unstable and the skin becomes rough and dull.
피부의 노화는 자유라디칼(free-radical)에 의한 세포내 물질의 산화적 손상이 원인이 된다. 즉, 하이드록시 라디칼, 슈퍼옥사이드 라디칼 등의 활성 산소와 같은 높은 반응성의 자유라디칼은 세포막을 구성하는 지방 성분을 산화시켜 세포막을 파괴하고, 이 결과로 단백질을 산화시키며 핵산의 기능을 정지시켜 결국 생체내 성분을 파괴하고 세포사멸을 일으킨다. 이와 같은 피부노화의 원인으로는 과다한 자외선 노출, 피부세포의 영양 결핍 및 화장품의 부작용 등을 들 수 있다.Skin aging is caused by oxidative damage of intracellular substances by free radicals. That is, highly reactive free radicals, such as active radicals such as hydroxy radicals and superoxide radicals, oxidize the lipid components constituting the cell membrane to destroy the cell membrane, thereby oxidizing the protein and stopping the function of the nucleic acid, It destroys its components and causes cell death. Such skin aging can be caused by excessive exposure to ultraviolet rays, nutritional deficiency of skin cells, and side effects of cosmetics.
생체내의 산화적 손상을 억제함으로써 피부의 노화를 예방하거나 줄일 수 있다. 한편 항산화 화장료는 지방 성분의 산화를 포함한 피부의 산화적 손상을 억제하여 피부의 노화를 예방, 또는 지연시키는 작용을 한다.By inhibiting oxidative damage in vivo, aging of the skin can be prevented or reduced. Antioxidant cosmetics, on the other hand, inhibit the oxidative damage of skin, including the oxidation of fat components, to prevent or delay skin aging.
특히, 기능성 화장품 중에서 한 제품에 두 가지 이상의 기능성을 갖는 복합기능성 화장품(예로서, 주름개선기능과 미백기능을 동시에 포함)에 대한 생산액 및 시장 성장률이 단일기능성 화장품에 비해 월등히 높게 나타나고 있다.In particular, the production amount and the market growth rate of a multi-functional cosmetic having two or more functionalities (for example, including a wrinkle-improving function and a whitening function at the same time) in one product among functional cosmetics are much higher than those of a single functional cosmetic product.
따라서 환경 친화적이고 자연지향적인 추세에 따라 화장품에 사용되는 유효성분들도 화학물질뿐만 아니라 식물 유래의 천연물이 그 유용성을 기반으로 하여, 피부에 부작용이 적은 천연 재료가 여러 가지 형태로 화장품에 배합되어 이용되고 있다.Therefore, according to the environment-friendly and nature-oriented trend, effective substances used in cosmetics are based on the usefulness of not only chemical substances but also natural substances derived from plants, and natural materials having few side effects on the skin are compounded in various forms in cosmetics .
대한민국 등록특허공보 제10-1117564호(2012.02.10.)에는, 과량의 소금 및/또는 설탕; 수상 성분; 음이온, 양쪽성 및 비이온 계면활성제; 및 폴리올을 포함하는 화장료 조성물로서, 상기 소금은 화장료 조성물 내에서 과포화 용해된 후 과포화 용해된 소금이 재결정화된 입자 상태로 존재하는 것이고, 수상 성분은 정제수이고, 음이온 계면활성제는 암모늄라우레스셀페이트이고, 양쪽성 계면활성제는 코카아미도프로필베타인이고, 비이온 계면 활성제는 코카마이드디이에이이고, 폴리올은 글리세린인 화장료 조성물이 개시되어 있다.Korean Patent Registration No. 10-1117564 (Feb. 10, 2012) discloses that excessive salt and / or sugar; Water phase component; Anionic, amphoteric and nonionic surfactants; And a polyol, wherein the salt is supersaturated and dissolved in the cosmetic composition, and the supersaturated and dissolved salt is present in the form of recrystallized particles, the water component is purified water, and the anionic surfactant is ammonium laureth sulfate , The amphoteric surfactant is cocamidopropyl betaine, the nonionic surfactant is cocamide di-is, and the polyol is glycerin.
상기 등록특허는 재결정화된 소금 및/또는 설탕 입자들에 의한 각질 제거, 피부 유연감, 혈행 촉진 효과 및 제형의 안전성을 얻을 수 있고, 소금 및/또는 설탕의 포화 용액 내에 용해된 상태로 잔류하는 소금 및/또는 설탕이 보습 기능을 나타내며, 음이온, 양쪽성 및 비이온 계면활성제를 함유함으로써 피부 세정 효과와 헹굼성이 우수하고, 또한 젤 형태로 사용 편리성이 우수하나, 과량의 소금을 함유함에 따라 소금 특유의 살균작용으로 인한 정상세포의 기능저하 및 그로 인해 콜라겐이 파괴되어 피부노화를 지나치게 유발하는 문제점이 있다.The patent is based on the finding that the patent is capable of obtaining exfoliation, skin amelioration, blood circulation promoting effect and formulation safety by recrystallized salt and / or sugar particles and of remaining in a saturated solution of salt and / Salt and / or sugar exhibits a moisturizing function. It contains anionic, amphoteric and nonionic surfactant, and is excellent in skin cleansing effect and rinsability. Also, it is excellent in ease of use in the form of a gel. However, There is a problem that the function of the normal cells due to the sterilization action peculiar to the salt is deteriorated and the collagen is destroyed thereby causing excessive aging of the skin.
따라서 종래기술의 한계점을 극복하고, 부작용이 적으며, 피부 건강에 핵심적인 요소인 항균, 항산화 및 항염효과가 모두 우수하여 피부의 상태를 개선시킬 수 있는 천연물 소재의 제품 개발이 요구되고 있다.Therefore, it is required to overcome the limitations of the prior art, to have fewer side effects, and to develop a product of a natural material capable of improving the condition of the skin, which is excellent in antimicrobial, antioxidant and anti-inflammatory effects, which are essential for skin health.
본 발명자는 천연물을 대상으로 하여 피부보호, 항산화 및 항균 작용을 동시에 갖는 무좀 예방 및 개선용 화장 또는 조성물을 개발하기 위하여 예의 연구한 결과, 후술하는 바와 같이, 천연물로 부터 유래된 조성물이 피부보호는 물론이고, 항산화 및 항균 작용을 갖는 것을 확인하고 본 발명을 완성하였다.The inventors of the present invention have made intensive studies to develop a cosmetic or composition for prevention and improvement of athlete's foot which has skin protection, antioxidant and antimicrobial action simultaneously with natural products, and as a result, Of course, it has been confirmed that it has an antioxidative and antimicrobial action and completed the present invention.
따라서, 본 발명의 목적은 티트리 오일 50 ~ 75 중량%, 아보카도 오일 10 ~ 30 중량%, 방풍뿌리 추출물 또는 편백 추출물 3 ~ 15 중량%, 호장근 추출물 3 ~ 15 중량%, 조릿대 추출액 1 ~ 10 중량%, 비타민 E 아세테이트 0.5 ~ 2 중량%, 폴리소르베이트(20) 0.5 ~ 2 중량%, 벤질알코올 0.01 ~ 0.05 중량% 및 티몰(thymol) 0.01 ~ 0.05 중량%를 포함하는 것을 특징으로 하는 무좀 예방 또는 개선용 외용제 조성물을 제공하는데에 있다.Accordingly, it is an object of the present invention to provide a method for producing a flavor enhancer which comprises 50 to 75% by weight of tea tree oil, 10 to 30% by weight of avocado oil, 3 to 15% Athlete's foot (50%), vitamin E acetate (0.5 to 2 wt%), polysorbate (20) 0.5 to 2 wt%, benzyl alcohol 0.01 to 0.05 wt% and thymol 0.01 to 0.05 wt% Or an external composition for improvement.
본 발명에 따른 무좀 예방 또는 개선용 조성물은 천연 오일을 주성분으로 하고 독성이나 피부자극 등의 부작용이 적을 뿐만 아니라 피부보호, 항산화 및 항균 작용을 동시에 나타내므로 무좀의 예방 및 개선을 위한 화장품 또는 제약 조성물로서 바람직하게 사용될 수 있다.The composition for prevention or improvement of athlete's foot according to the present invention is a cosmetic or pharmaceutical composition for prevention and improvement of athlete's foot since the composition for preventing or improving athlete's foot is natural oil as a main ingredient and exhibits skin protection, antioxidant and antibacterial action simultaneously as well as less side effects such as toxicity and skin irritation Can be preferably used.
도 1은 실시예 조성물의 DPPH 유리 라디칼 소거능을 나타내는 그라프도이다.BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a graph showing DPPH free radical scavenging performance of the example compositions.
도 2는 실시예 조성물의 히드록시 라디칼 소거능을 나타내는 그라프도이다.2 is a graph showing the hydroxy radical scavenging activity of the example composition.
도 3은 실시예의 조성물의 Fe2+ 킬레이팅 에세이 분석 결과를 나타내는 그라프도이다.3 is a graph showing the results of Fe 2+ chelating assay analysis of the composition of the examples.
도 4는 실시예 조성물의 아질산 소거능 분석 결과를 나타내는 그라프도이다(pH 1.2).4 is a graph (pH 1.2) showing the nitrite scavenging activity of the composition of Example.
본 발명은, 일면에 있어서, 티트리 오일 50 ~ 75 중량%, 아보카도 오일 10 ~ 30 중량%, 방풍뿌리 추출물 또는 편백 추출물 3 ~ 15 중량%, 호장근 추출물 3 ~ 15 중량%, 조릿대 추출물 1 ~ 10 중량%, 비타민 E 아세테이트 0.5 ~ 2 중량%, 폴리소르베이트(20) 0.5 ~ 2 중량%, 벤질알코올 0.01 ~ 0.05 중량% 및 티몰(thymol)0.01 ~ 0.05 중량%를 포함하는 것을 특징으로 하는 무좀 예방 또는 개선용 외용제 조성물을 제공한다.In one aspect, the present invention provides a method for producing an extract, comprising, in one aspect, 50 to 75 wt% of tea tree oil, 10 to 30 wt% of avocado oil, 3 to 15 wt% of windshield extract or cottonwood extract, 3 to 15 wt% A thickening agent for athlete's foot comprising 0.5 to 2% by weight of vitamin E acetate, 0.5 to 2% by weight of vitamin E acetate, 0.5 to 2% by weight of polysorbate 20, 0.01 to 0.05% by weight of benzyl alcohol and 0.01 to 0.05% Prevention or amelioration.
이하, 본 발명의 무좀 예방 및 개선용 조성물에 대하여 더욱 상세하게 설명한다.Hereinafter, the composition for prevention and improvement of athlete's foot according to the present invention will be described in more detail.
본 발명의 조성물에 있어서 주요 성분중 하나인 티트리(Tea Tree) 오일은 호주에서 자생하던 수종으로 미르타시아(Myrtaceae)속에 속하는 식물로서, 잎속에 입자상의 물질이 함유되어 있고 잎을 분쇄하면 입자상의 물질로부터 티트리오일이 얻어진다. 티트리오일은 알파-피넨 2.5%, 알파-터피넨 9.1%, 파라-시멘 3.9%, 1.8-시네오올 4.3%, 감마-터피넨 24.6%, 알파-터피네올 2.3%, 터피넨-4-올 42.1%, 터피놀렌 4.1% 및 잔량의 미량성분들로 구성되어 있는 것으로, 향균성의 효과 뿐만아니라 소염, 진통 및 상처치료 효과가 있으며, 이의 효과는 인삼과 마찬가지 로 그 작용기전이 명확히 밝혀지지 않았다. 본 발명에서는 티트리 오일은 잎을 사용하여 압착하거나 정류하여 사용하는 것이 바람직하다.Tea Tree Oil, one of the main components of the composition of the present invention, is a plant native to Australia and belongs to the genus Myrtaceae. It contains particulate matter in the leaves. When the leaves are crushed, Lt; / RTI > is obtained. The tea trioyl contained 2.5% of alpha-pinene, 9.1% of alpha-terpinene, 3.9% of para-cymene, 4.3% of 1.8-cineol, 24.6% of gamma-terpinene, 2.3% of alpha-terpineol, 42.1%, terpinolene 4.1%, and trace amounts of residual components. The effect of antibacterial as well as antiinflammatory, analgesic and wound treatments is effective. Its action mechanism is not clear as its effect is similar to that of ginseng. In the present invention, tea tree oil is preferably compressed or rectified using leaves.
아보카도(Persea americana Mill.)는 멕시코와 중앙아메리카 일대에서 유래된 과일로서, 전 세계적으로 널리 소비되고 있다. 아보카도 오일은 과육과 껍질을 압착하여 만들어지는 식물성 기름으로서, 아보카도의 가장 대표적인 효능을 보면, 아보카도에는 지용성 비타민의 한 종류인 토코페롤이라 부르는 비타민E가 풍부하여 우리 몸에서 활성산소를 제거하고 노화를 억제하며 심장병과 암을 예방하는 효능을 지닌 것으로 알려져 있다. 본 발명에서 아보카도 오일은 과육을 압착하거나 정류하여 사용하는 것이 바람직하다.Avocado (Persea americana Mill.) Is a fruit originating in Mexico and Central America, and is widely consumed worldwide. Avocado oil is a vegetable oil made by squeezing flesh and skin. Avocado is rich in vitamin E called tocopherol, which is one kind of fat-soluble vitamin. It removes active oxygen from our body and suppresses aging. And is known to have the effect of preventing heart disease and cancer. In the present invention, the avocado oil is preferably used by pressing or rectifying the flesh of the flesh.
방풍(Saposhnikoviae divaricata Schiskin)은 산형화목 미나리과(Umbelliferae)에 속하는 세해살이 식물로서 진방풍, 산방풍, 병풍나물, 산방풍나무, 방풍나무뿌리 등으로 불리는 다년생 초본으로서 건조한 모래흙으로 된 풀밭에서 자생하고 있으며, 우리나라를 비롯하여 중국, 베트남, 몽골 등에 널리 분포하고 있다. 한방에 의한 방풍의 주요 효능으로는 발한, 해열, 진통, 이뇨, 중풍, 사지마비, 진해, 거담, 치통, 신경통, 류마티즘 등을 치료하며, 항균작용 및 바이러스 억제작용이 있는 것으로 알려져 있다.The windshield (Saposhnikoviae divaricata Schiskin) is a perennial herb that belongs to the mountain-type Umbelliferae (Umbelliferae) and is a perennial herb called jinhwa wind, mountain wind wind, screen wind herb, mountain windbreak tree, It is widely distributed in Korea, China, Vietnam and Mongolia. It is known that the main effects of windblown by oriental medicine are sweating, fever, analgesic, diuretic, paralysis, limb paralysis, shinhae, geumdam, toothache, neuralgia, rheumatism and so on.
편백(Chamaecyparis obtusa)은 측백나무과의 상록교목으로, 회목, 히노끼 및 노송나무라고도 한다. 높이는 30~40 m이고 폭은 1~2 m 가량이며, 나무껍질은 적갈색이고, 작은 바늘 모양의 잎이 가지에 밀생한다. 일본과 한국 남부에 분포하고, 성분에는 γ-카디넨(cadinene), α-테르피네올(terpineol) 및 보르네올(borneol) 등이 함유되어 있으며, 잎과 목재에는 1%의 정유가 함유되어 있다. 편백은 항원에 대한 항체를 생성시키는 작용을 하여 체내의 면연력을 향상시켜주고, 아토피, 천식 및 비염 등 알러지 질환을 일으키는 집먼지 진드기 퇴치를 위한 천연살충제로 많이 이용된다. 편백은 잎 또는 줄기, 가지를 추출한 것을 사용하는 것이 좋다. 상기 방풍과 편백 추출물은 단독으로 또는 혼합물 형태로 사용하여도 좋다.Chamaecyparis obtusa (Chamaecyparis obtusa) is an evergreen arborescent tree, and it is also called ashiko, hinoki and cypress. It is 30 ~ 40m in height and 1 ~ 2m in width. The bark is reddish brown, and small needle-shaped leaves are densely grown on branches. It is distributed in Japan and southern part of Korea. It contains γ-cadinene, α-terpineol and borneol, and leaves and wood contain 1% essential oil. . It is used as a natural insecticide for the prevention of house dust mites causing allergic diseases such as atopy, asthma and rhinitis. It is recommended to use the leaves, stems, and branches extracted from the leek. The windshield and the leathery extract may be used singly or in the form of a mixture.
호장근 (Rhizoma Polygoni Cuspidati)은 마디풀과 (Polygonaceae)에 속하는 식물로서 산지에서 자라고, 한국·일본·타이완 및 중국 등지에 분포한다. 한방에서는 뿌리를 호장근이라고 하며 완화·이뇨 및 통경제로 사용하고, 민간에서는 진정제로 쓴다. 어릴 때 줄기가 호피같이 생겨서 호장근이라는 이름을 가진다. 호장근은 뿌리와 뿌리 줄기(근경)를 추출한 것을 사용할 수 있다. Rhizoma Polygoni Cuspidati is a plant belonging to the family Polygonaceae and grows in mountainous areas and is distributed in Korea, Japan, Taiwan and China. In one room, the roots are called hojanggun, and they are used as relaxation, diuretic, and tongue economy, and as a sedative in the private sector. When it is young, the stem looks like a hoof, and it has the name Ho Chang Geun. Root can be obtained by extracting roots and rootstocks.
조릿대는 벼과의 여러 해살이 식물로서, 우리나라 중부이남 지방 및 제주도의 산에 빽빽하게 무리지어 흔히 자란다. 그리고 조릿대 줄기는 곧게 서며 높이 1∼2m, 지름 3∼6mm이고 포는 2∼3년간 줄기를 싸고 있으며 털과 더불어 끝에 바소꼴의 잎조각이 있다. 마디 사이는 역모(逆毛)와 흰 가루로 덮이지만 4년째 잎집 모양의 잎이 벗겨지면서 없어진다. 잎은 긴 타원상 바소꼴로 길이 10∼25cm이고 끝으로 갈수록 뾰족하거나 꼬리처럼 길다. 잎 양면에 털이 없거나 뒷면 밑동에 털이 있고 가장자리에 가시 같은 잔 톱니가 있으며 잎집에 털이 있다. 조릿대에는 열을 내리고 독을 풀며, 가래를 없애고 소변을 잘 나오게 하며, 신진대사를 원활하게 하게 하는 것으로 알려져 있다. 조릿대는 잎, 줄기 및 뿌리를 추출한 것을 사용할 수 있다.Sasae is a plant of various ages of paddy field and grows frequently in the southern part of Korea and the mountains of Jeju Island. The stem is straight up to 1 ~ 2m in height, 3 ~ 6mm in diameter, and the bract covers the stem for 2 ~ 3 years. The nodes are covered with inverted hair and white powder, but the leaves of the sheath-shaped leaves disappear after 4 years. Leaves are long, oval-shaped, 10 ~ 25cm long, pointed like a tail or long as the tail. There are no hairs on both sides of the leaf, there are hairs on the base of the back side, there are saw teeth like thorn on the edge, and the sheath has hairs. It is known to reduce fever and poison, remove sputum, urinate well, and smooth metabolism. Sasa can be obtained by extracting leaves, stems and roots.
상기 티트리 오일, 아보카도 오일을 포함하는 식물성 오일은 잎이나 과실 또는 열매를 식물을 압착하여 얻거나 또는 원료에 1:2 내지 1:20 중량 비율로 추출용매를 가하여 환류냉각장치(reflux condenser)에 넣고 2~3 시간 동안 가열 증류시킨 후 냉각시킨 후, 냉각시킨 추출물을 5~7시간 동안 여과하여 추출물을 개별적으로 제조할 수 있다. 별법으로, 원액 오일을 상업적으로 구입하여 이용하여도 좋다.The vegetable oil containing the tea tree oil and the avocado oil may be obtained by squeezing a leaf, a fruit or a fruit into plants or by adding an extraction solvent to the raw material at a weight ratio of 1: 2 to 1:20, and adding the extract to a reflux condenser After cooling by heating distillation for 2 to 3 hours, the extracted extract can be separately filtered for 5-7 hours. Alternatively, the crude oil may be purchased commercially and used.
편백은 잎 또는 줄기, 가지 등에 추출용매를 가하여 열수추출, 냉침 또는 온침 추출할 수 있다. 이 경우 편백에 대하여 추출용매를 중량비로 2 내지 20배를 가하여 혼합한 후 70 내지 125℃에서 2 내지 24시간 동안 추출하고, 여과하고 농축하여 추출물을 얻을 수 있다Leaves, stems, branches and the like can be extracted by hot water extraction, cold-watering or warm-up extraction. In this case, the extraction solvent is mixed with the extraction solvent at a weight ratio of 2 to 20 times, and the mixture is extracted at 70 to 125 ° C for 2 to 24 hours, filtered and concentrated to obtain an extract
상기 조릿대, 호장근 및 방풍 뿌리는 깨끗이 세척하여 건조하여 세절한 다음 원료 중량의 5배 내지 10 배의 추출용매를 더하여 고압멸균솥에 넣고 65 ~ 125℃의 온도에서 2 내지 6시간, 바람직하게는 5시간 동안 가열시켜 추출하여 여과하고 농축하여 얻을 수도 있다The bamboo shoots, bamboo shoots, and windshield roots are thoroughly cleaned, dried, and then added with an extraction solvent 5 to 10 times the weight of the raw materials. The resulting mixture is placed in a autoclave autoclave and heated at 65 to 125 ° C for 2 to 6 hours, Extraction by heating for 5 hours, filtration and concentration may be obtained
여기서 추출용매로 물, 탄소수 1 내지 4의 저급 알코올, 다가 알코올 또는 이들의 혼합물로부터 선택된 적어도 어느 하나를 이용할 수 있다. 탄소수 1 내지 4의 저급 알코올로 메탄올, 에탄올 등을 이용할 수 있고, 다가 알코올로 부틸렌글리콜 및 프로필렌글리콜, 펜틸렌글리콜 등을 이용할 수 있다. 그리고 혼합물로는 물 및 저급 알코올의 혼합물, 물 및 다가 알코올의 혼합물, 저급 알코올 및 다가 알코올의 혼합물, 또는 물 및 저급알코올 및 다가알코올의 혼합물을 이용할 수 있다.The extraction solvent may be at least one selected from water, lower alcohols having 1 to 4 carbon atoms, polyhydric alcohols, and mixtures thereof. As the lower alcohol having 1 to 4 carbon atoms, methanol, ethanol and the like can be used. As the polyhydric alcohol, butylene glycol, propylene glycol, pentylene glycol and the like can be used. Mixtures of water and lower alcohols, mixtures of water and polyhydric alcohols, mixtures of lower alcohols and polyhydric alcohols, or mixtures of water and lower alcohols and polyhydric alcohols can be used as the mixture.
본 발명은 천연 식물들로부터 피부보호, 항산화작용 및 항균 특성의 다기능성을 갖는 성분들과 이들의 최적의 조합비를 찾아낸 것에 주된 특징이 있는 것으로서, 상기 티트리 오일, 아보카도 오일, 방풍 뿌리 추출물 또는 편백 추출물, 비타민 E 아세테이트는 피부보호 작용, 항산화 작용, 및 항균 작용을 나타내는 주요 성분들이고, 조릿대 추출물은 방부제로서 기능하며, 폴리소르베이트는 분산제로서 기능하며, 벤질알코올과 티몰은 방부제 및 안정화제로서 작용한다.The present invention is mainly characterized in finding ingredients having multifunctional properties such as skin protection, antioxidant activity and antibacterial property from natural plants and an optimal combination ratio thereof. The tea tree oil, avocado oil, Extracts and vitamin E acetates are the main components of skin protection, antioxidant, and antibacterial activity. Sasa extract acts as a preservative. Polysorbate acts as a dispersant. Benzyl alcohol and thymol act as preservatives and stabilizers. do.
상기 본 발명에 따른 조성물의 조성비는 각각의 성분이 갖는 유효 용량과 부작용 등을 고려하여 설정한 것이며, 그 비율의 범위를 벗어나는 경우에는 효과가 떨어질 우려가 있다.The composition ratio of the composition according to the present invention is set considering the effective dose and side effects of each component, and if the ratio is out of the range, the effect may be deteriorated.
본 발명에서 목적하는 효과를 상기한 천연 식물 추출물을 최적의 비율로 배합함으로써 각종 미생물의 생육을 저지하고 세포보호 및 항산화 효과를 극대화시킬 수 있다.The desired effects of the present invention can be achieved by mixing the above-mentioned natural plant extracts at an optimum ratio, thereby preventing growth of various microorganisms and maximizing cell protection and antioxidative effects.
상기 티트리오일의 사용량이 50중량% 미만인 경우에는 항균 작용 효과가 미약하고, 75 중량%를 초과할 경우에는 첨가량에 따른 상승 효과가 없어 경제성이 문제가 된다. 또한, 아보카도 오일은 10중량% 이하에서는 항산화 및 방부 효과가 미약하고, 30중량%를 초과하는 경우에는 각 성분과의 조합에 의한 상승효과가 이루어지지 않을 수 있다. 또한, 방풍뿌리 추출물 또는 편백 추출물, 호장근 추출물은 3 중량% 이하에서는 피부보호, 항산화 및 살균 효과가 약하고, 15 중량%를 초과하는 경우에는 전체적인 조성과 균형을 이루지 못하여 비경제적이다. 조릿대 추출물은 1 ~ 10 중량%, 비타민 E 아세테이트는 0.5 ~ 2 중량%, 폴리소르베이트(20)은 0.5 ~ 2 중량%, 벤질알코올은 0.01 ~ 0.05 중량% 그리고 티몰(thymol)은 0.01 ~ 0.05 중량%로 포함됨으로써 전체적인 조성물의 안정적인 조화와 다양한 기능성을 최적으로 발휘할 수 있다.When the amount of the tea trioyl is less than 50 wt%, the antibacterial effect is insufficient. When the amount of the tea trioyl is more than 75 wt%, the effect of increasing the amount of the tea trioyl is insufficient. In addition, the antioxidative and preservative effect of avocado oil is less than 10% by weight, and when it is more than 30% by weight, the synergistic effect by combination with each ingredient may not be achieved. The skin protection, antioxidant and germicidal effect are less than 3% by weight of the roots extract or the cotton bud extract and the silkworm extract, and less than 15% by weight are uneconomical because the composition is not balanced with the whole composition. The content of the sage extract is 1 to 10% by weight, the content of vitamin E acetate is 0.5 to 2% by weight, the content of polysorbate 20 is 0.5 to 2% by weight, the content of benzyl alcohol is 0.01 to 0.05% by weight and the content of thymol is 0.01 to 0.05% %, It is possible to optimally exhibit stable coordination and various functions of the entire composition.
본 발명에 따른 조성물은 화학 합성제가 아닌 천연 물질의 추출물을 포함하고 있으므로 후술하는 실시예 및 시험예의 결과로부터 잘 알 수 있는 바와 같이 피부에 대한 자극성이나 독성이 없어서 안정성이 우수하며, 피부보호 등에 탁월한 효과를 갖고 있을 뿐만 아니라 무좀균을 포함한 세균에 대한 항균성, 아토피염 피부염 치유, 유아의 진물 치료, 피부에 대한 보호 효과가 있어서 피부촉감 개선 등의 기능성이 있으므로 이러한 기능성을 요하는 화장품이나 치료제로서 사용할 수 있다.Since the composition according to the present invention contains an extract of a natural substance, which is not a chemical synthesis agent, it can be seen from the results of Examples and Test Examples described later that there is no irritation or toxicity to the skin and thus it is excellent in stability. But also can be used as a cosmetic or therapeutic agent requiring such functionality since it has antimicrobial activity against bacteria including aceotrophic bacteria, healing of atopic dermatitis, therapeutic treatment of infant's dirt, protection against skin and improvement of skin texture have.
따라서, 본 발명은, 추가의 일면에 있어서, 유효 성분으로서 상기 조성물 및 화장품 또는 제약학상 허용되는 담체를 포함하는 무좀 개선용 조성물을 제공한다.Accordingly, the present invention provides, in a further aspect, a composition for improving athlete's foot comprising the composition and cosmetics or a pharmaceutically acceptable carrier as an active ingredient.
상기 화장품의 제형은 화장품 제조 분야에서 잘 알려진 통상적인 방법에 의해 제조할 수 있다. The formulations of the cosmetics may be prepared by conventional methods well known in the art of cosmetics.
이들 화장품의 부형제로서는 사용 목적에 따라 달라질 수 있으나, 일반적으로 글리세린, 부틸렌글리콜, 프로필렌글리콜 등의 방부제 또는 식물성 방부제, 정제수, 보습제, 벌크화제, 크림제, 계면활성제, pH 조정제, 향료 등을 적량 혼합하여 원하는 제형의 형태에 따라 제조하는 것이 바람직하다.The excipients of these cosmetics may vary depending on the purpose of use, but they generally contain a preservative such as glycerin, butylene glycol or propylene glycol or a vegetable preservative, a purified water, a moisturizer, a bulking agent, a cream agent, a surfactant, a pH adjuster, It is preferable to mix them according to the form of the desired formulation.
본 발명의 조성물은 각각 통상의 방법에 따라 현탁액, 에멀젼, 에어로졸 등의 외용제의 형태로 제형화하여 바람직하게 사용할 수 있다.The composition of the present invention can be suitably formulated in the form of an external preparation such as a suspension, emulsion or aerosol according to a conventional method.
본 발명의 조성물이 약제학적 조성물로 제조되는 경우에는 약제학적으로 허용되는 통상의 담체를 추가로 포함하는 것이 바람직할 수 있다. When the composition of the present invention is prepared from a pharmaceutical composition, it may be preferable to further include a conventional pharmaceutically acceptable carrier.
본 발명의 약제학적 조성물의 투여량은, 그 제제형태, 투여방법, 사용 목적 및 이것에 적용되는 환자의 연령, 체중, 증상에 따라서 적절히 설정되고, 일정하지 않지만 일반적으로는 제제 중에 함유되는 유효성분의 양은 성인 1일당 예컨대 10㎍~200 ㎎/㎏이다. 그러나, 당업자는 특정 시약의 약물동력학적인 특성 및 그의 투여 모드 및 경로; 수여자의 나이, 건강, 체중; 증상의 성질 및 정도, 동시 치료의 종류, 치료의 빈도 및 목적하는 효과 등의 공지의 요인에 따라서 투여량이 변화함은 이해할 것이다. The dosage of the pharmaceutical composition of the present invention is suitably set in accordance with the form of the preparation, the method of administration, the purpose of use, and the age, body weight, and symptoms of the patient to which the active ingredient is administered. For example, 10 mu g to 200 mg / kg per day for an adult. However, those skilled in the art will appreciate that the pharmacokinetic properties of a particular reagent and its mode and route of administration; Age, health, weight; It will be understood that the dosage varies depending on known factors such as the nature and extent of the symptoms, the type of concurrent treatment, the frequency of treatment and the desired effect.
<실시예><Examples>
이하, 본 발명을 실시예를 들어 더욱 상세히 설명한다. 그러나, 이들 실시예는 본 발명의 이해를 돕기 위해 기술한 것으로서 발명의 내용 및 범위를 제한하지 않는다.Hereinafter, the present invention will be described in more detail with reference to examples. However, these embodiments are described for the purpose of helping understanding of the present invention, and do not limit the content and scope of the invention.
실시예 1: 식물 정유의 제조Example 1: Preparation of plant essential oil
믹서로 곱게 마쇄된 티트리잎 1 Kg을 5배수의 추출용매(정제수 및 30% 주정)를 가하여 환류냉각장치(reflux condenser)에 넣고 2~3 시간 동안 가열 증류시킨 후 냉각시키고, 냉각시킨 추출물을 6시간 동안 여과(Toyo No. 2)하여 추출물을 얻었다. 티트리의 추출 수율은 18.6%이고, 굴절당도계로 측정한 brix는 2.32%이었다. 이어서, 여액을 60℃의 온도에서 -0.08 MPA의 감압하에서 3~8시간 동안 농축하였다. 고형분의 brix는 각각 35.6(정제수) 및 37.8(주정)로 측정되었다. 마찬가지로 아보카도 과육을 처리하여 오보카도 오일을 얻었다. 고형분의 brix는 각각 53.6(정제수) 및 57.4(주정)로 측정되었다.Add 1 Kg of finely ground tea tree leaves to a reflux condenser by adding 5 times of extraction solvent (purified water and 30% alcohol) with a mixer, heat distill for 2 ~ 3 hours, cool, The mixture was filtered (Toyo No. 2) for 6 hours to obtain an extract. The extraction yield of tea tree was 18.6%, and the brix measured by refractometer was 2.32%. The filtrate was then concentrated under a reduced pressure of -0.08 MPA at a temperature of 60 DEG C for 3 to 8 hours. The brix of solids was measured at 35.6 (purified water) and 37.8 (alcohol), respectively. Similarly, avocado oil was obtained by treating avocado pulp. The brix of solids was measured as 53.6 (purified water) and 57.4 (alcohol), respectively.
실시예 2: 펀백 추출물의 제조Example 2: Preparation of fern extract
편백 잎 1Kg에 5배수의 추출용매(정제수 및 30% 주정)를 가한 후, 70 내지 125℃에서 2 내지 12시간 동안 추출하여 편백 추출물을 얻었다. 편백의 수율은 30.5%이고, brix는 4.1%이었다. 이어서, 추출물을 종이 여과지로 여과하여 이물질을 걸러낸 후, 여액을 60℃의 온도에서 -0.08 MPA의 감압하에서 8시간 동안 농축하였다. 고형분의 brix는 각각 40.1(정제수) 및 42.3(주정)으로 측정되었다. Five milliwatts of extraction solvent (purified water and 30% alcohol) was added to 1 kg of soft white leaf, followed by extraction at 70 to 125 ° C for 2 to 12 hours to obtain a cottonwood extract. The yield of the whiteness was 30.5% and the brix was 4.1%. Subsequently, the extract was filtered with a paper filter paper to filter off the foreign substances, and the filtrate was concentrated at a temperature of 60 ° C under a reduced pressure of -0.08 MPA for 8 hours. The brix of solids was measured as 40.1 (purified water) and 42.3 (alcohol), respectively.
실시예 3: 호장근, 방풍뿌리 및 조릿대 추출물의 제조Example 3: Preparation of Hojangun, Root Root and Sasa extract
호장근, 방풍 뿌리 및 조릿대 1 Kg를 깨끗이 세척하여 건조하여 세절한 다음 원료 중량의 5배의 정제수 및 30%주정을 더하여 고압멸균솥에 넣고 65 ~ 125℃의 온도에서 2 내지 6시간 동안 가열시켜 추출하여 여과하고 농축하여 추출물을 얻었다. 호장근 고형분의 brix는 각각 43.6(정제수) 및 45.8(주정)로 측정되었고, 방풍 추출물의 고형분의 brix는 각각 55.2(정제수) 및 56.8(주정)로 측정되었으며, 조릿대 추출물의 고형분의 brix는 각각 55.2(정제수) 및 56.8(주정)로 측정되었다.After washing 1 Kg of silkworm roots and bamboo shoots thoroughly, it was dried, and then, purified water of 5 times of the raw material weight and 30% of the raw material were added to the autoclave and heated in a high pressure sterilizing pot at a temperature of 65 to 125 ° C for 2 to 6 hours Extracted, filtered and concentrated to obtain an extract. The brix of solids content was measured as 43.6 (purified water) and 45.8 (alcohol), respectively, and the brix of the extract of windshield was 55.2 (purified water) and 56.8 (Purified water) and 56.8 (alcohol).
실시예 4~8: 천연 추출물을 포함하는 조성물의 제조Examples 4-8: Preparation of a composition comprising a natural extract
상시 실시예 1 내지 3에서 얻어진 각 성분들을 다음의 표 1에 나타낸 배합비로 배합하고 무좀 예방용 조성물을 제조하였다. 각 식물오일 및 추출물은 정제수 추출물과 주정 추출물을 1:1 중량비로 혼합하여 사용하였다.Each of the components obtained in Examples 1 to 3 was formulated in a formulation ratio shown in Table 1 below to prepare a composition for preventing athlete's foot. Each plant oil and extract was mixed with purified water extract and alcohol extract at a weight ratio of 1: 1.
성분함량(g)Component Content (g) 실시예4Example 4 실시예5Example 5 실시예6Example 6 실시예7Example 7 실시예8Example 8 비교예Comparative Example
티트리오일 Tea trio day 5050 5555 5353 6565 7070 7070
아보카도오일 Avocado oil 1010 3030 1010 1010 2020 3030
방풍 추출물Windshield extract 1515 3.03.0 1010 3.03.0 -- --
편백 추출물Leek extract -- 3.03.0 1515 -- 4.04.0 --
호장근 추출물Hojangun extract 12.012.0 1313 8.08.0 1515 3.03.0 --
조릿대 추출물 Sasa extract 1010 5.55.5 2.52.5 6.06.0 1.01.0 --
비타민 E-아세테이트Vitamin E-acetate 0.940.94 0.940.94 0.500.50 2.02.0 1.01.0 --
폴리소르베이트(20)Polysorbate (20) 2.02.0 0.500.50 0.900.90 0.90.9 0.90.9 --
벤질 알코올Benzyl alcohol 0.010.01 0.050.05 0.050.05 0.050.05 0.050.05 --
티몰Thymol 0.050.05 0.010.01 0.050.05 0.050.05 0.050.05 --
합계 Sum 100100 100100 100100 100100 100100 100100
시험예 1: 천연물 추출 조성물의 항산화 효과 분석Test Example 1: Antioxidative effect analysis of natural extract composition
1.1) DPPH 라디칼 소거능 분석1.1) Analysis of DPPH radical scavenging ability
시험관 내 항산화능 분석은 517nm에서 최대 흡광도를 보이는 자유 라디칼인 DPPH와 실시예 4~8의 조성물을 반응시켜 노란색이 되면서 흡광도 값이 낮아지는 것을 이용하여 항산화 효과를 측정하였다. DPPH 유리 라디칼 소거능은 96-웰 마이크로플레이트 중의 메탄올에 녹인 실시예의 조성물과 에탄올에 녹인 DPPH 0.1 mM을 포함하는 반응 혼합물을 사용하여 결정하였다. 추출물들을 DPPH 용액 0.6 mL과 혼합한 후 실온에서 20 분동안 인큐베이션시켰다. 그 후 반응 혼합물의 흡광도를 517 nm에서 측정하였다. 라디칼 소거능의 억제 백분율은 에탄올 처리군 또는 아스코르브산(100㎍)-처리군과 비교하여 결정하였다. DPPH 유리 라디칼 소거 능의 백분율은 다음의 식으로 계산하였다.The in vitro antioxidant activity was measured by reacting the free radical DPPH having the maximum absorbance at 517 nm with the compositions of Examples 4 to 8 to determine the antioxidative effect using the absorbance value lowering in yellow. DPPH free radical scavenging activity was determined using a reaction mixture comprising the composition of the example dissolved in methanol in a 96-well microplate and 0.1 mM DPPH dissolved in ethanol. The extracts were mixed with 0.6 mL of DPPH solution and incubated at room temperature for 20 minutes. The absorbance of the reaction mixture was then measured at 517 nm. The percent inhibition of radical scavenging was determined in comparison to the ethanol treated group or the ascorbic acid (100 [mu] g) treated group. The percentage of DPPH free radical scavenging activity was calculated by the following equation.
(%) = (Abscontrol without sample-Abssample)/Abscontrol without sample Х 100 (%) = (Abs control without sample - Abs sample ) / Abs control without sample Х 100
그 결과를 도 1에 나타내었다. 도 1은 실시예 조성물의 DPPH 유리 라디칼 소거능을 나타내는 그라프도이다. Con, 음성 대조군으로서 메탄올(vehicle) 처리군; AA, 양성대조군으로서 아스코르브산(1 mg/ml) 처리군; 시료 100㎍ 시료 처리군(이하, 시험예에서 동일함).The results are shown in Fig. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a graph showing DPPH free radical scavenging performance of the example compositions. Con, vehicle treated group as a negative control group; AA, treated with ascorbic acid (1 mg / ml) as a positive control group; Sample of 100 시 sample (hereinafter, the same as in the test example).
양성대조군 ascorbic acid(AA)은 1 mg/ml 농도에서 자유라디칼을 98.36 ± 1.32% 억제시켰다. 시료 처리군은 각각 91.25±0.12(실시예 4), 92.45±0.65(실시예 5), 93.66±0.23(실시예 6), 96.21±0.15(실시예 7), 92.57±0.24(실시예 8), 47.35±0.27(비교예) 억제시켰다(도 1). Positive control ascorbic acid (AA) inhibited free radicals by 98.36 ± 1.32% at 1 mg / ml concentration. The results are shown in Table 1. The sample treatment groups were 91.25 ± 0.12 (Example 4), 92.45 ± 0.65 (Example 5), 93.66 ± 0.23 (Example 6), 96.21 ± 0.15 (Example 7), 92.57 ± 0.24 47.35 +/- 0.27 (comparative) inhibition (Figure 1).
1-2) Hydroxyl 라디칼 소거능 분석1-2) Analysis of hydroxyl radical scavenging ability
Hydroxyl 라디칼 소거능 분석은 Fenton's reagent에 의해 발생되는 Hydroxyl 라디칼과 실시예의 조성물을 반응시켜 흡광도 값이 낮아지는 것을 이용하여 항산화 효과를 측정하였다.Hydroxyl radical scavenging activity was measured by reacting hydroxyl radicals generated by Fenton ' s reagent with the composition of the examples to lower the absorbance value.
실시예의 조성물을 100 μM EDTA, 1 mM H2O2, 및 2.8 mM 데옥시리보오스를 함유하는 반응혼합물에 첨가하였다. 부피는 20 mM pH 7.4 인산염 완충액으로 보충하여1 mL가 되게 한 후 37 ℃에서 1 시간 동안 인큐베이션시켰다.Embodiment the composition 100 μM EDTA, it was added to the reaction mixture containing oxy-ribose 1 mM H 2 O 2, and 2.8 mM to. The volume was supplemented with 20 mM pH 7.4 phosphate buffer to make 1 mL and then incubated at 37 ° C for 1 hour.
이어서 혼합물을 수조에서 95℃까지 15 분동안 가열하고, 각각의 2.8%TCA 및 0.5% TBA 1 mL을 첨가하였다. 냉각 후 4800 rpm으로 15 분 동안 원심분리 시켰다. 상층액의 흡광도를 532 nm에서 측정하였다. 비교분석을 위해 음성대조군은 vehicle(phosphate buffer)을 처리하였고 양성대조군은 ascorbic acid를 처리하여 Hydroxyl 라디칼 소거능을 분석하였다.The mixture was then heated in the bath to 95 캜 for 15 minutes, and each of the 2.8% TCA and 1% 0.5% TBA was added. After cooling, the mixture was centrifuged at 4800 rpm for 15 minutes. The absorbance of the supernatant was measured at 532 nm. For comparative analysis, negative control group was treated with vehicle (phosphate buffer) and positive control group was treated with ascorbic acid to analyze hydroxyl radical scavenging ability.
도 2는 실시예 조성물의 히드록시 라디칼 소거능을 나타내는 그라프도이다. 양성대조군 ascorbic acid(AA)은 1 mg/ml 농도에서 자유라디칼을 51.69 ± 1.13% 억제시켰다. 시료 처리군은 각각 41.25±0.67(실시예 4), 42.75±0.76(실시예 5), 47.87±0.83(실시예 6), 45.21±0.96(실시예 7), 39.01±0.89(실시예 8), 23.50±1.23(비교예) 억제시켰다(도 2). 2 is a graph showing the hydroxy radical scavenging activity of the example composition. Positive control ascorbic acid (AA) inhibited free radicals by 51.69 ± 1.13% at 1 mg / ml concentration. The results are shown in Table 1. The sample treatment groups were 41.25 ± 0.67 (Example 4), 42.75 ± 0.76 (Example 5), 47.87 ± 0.83 (Example 6), 45.21 ± 0.96 (Example 7), 39.01 ± 0.89 23.50 ± 1.23 (comparative) (FIG. 2).
1-3) 총 폴리페놀 및 총 플라보노이드 함량 분석1-3) Analysis of total polyphenol and total flavonoid content
실시예의 조성물들을 Folin-Denis 시약 100 μL과 혼합한 후, 실온(RT, 22-24℃에서 3 분 동안 인큐베이션시켰다. 반응 혼합물을 10 % 탄산 나트륨 100 ㎕로 중화시키고, 1 시간 동안 인큐베이션시켰다. 마이크로플레이트 판독기로 760 nm에서 흡광도를 측정하였다. 폴리페놀 함량을 표준으로서 갈릭산을 사용하여 계산하였다.The compositions of the examples were mixed with 100 μL of Folin-Denis reagent and incubated for 3 minutes at room temperature (RT, 22-24 ° C.) The reaction mixture was neutralized with 100 μl of 10% sodium carbonate and incubated for 1 hour. Absorbance was measured at 760 nm with a plate reader. Polyphenol content was calculated using gallic acid as standard.
그 결과를 표 2에 나타내었다. 각 조성물의 폴리페놀 함량 및 플라보노이드 함량은 비교예의 것에 상당히 현저히 높았다.The results are shown in Table 2. The polyphenol content and flavonoid content of each composition were significantly higher than those of the comparative examples.
성분   ingredient 실시예4Example 4 실시예5Example 5 실시예6Example 6 실시예7Example 7 실시예8Example 8 비교예Comparative Example
폴리페놀Polyphenol (mg/g)(mg / g) 56.72±1.5156.72 + 1.51 57.32±0.9857.32 + - 0.98 52.77±0.5452.77 + - 0.54 56.45±0.7156.45 + 0.71 52.34±0.3552.34 + - 0.35 25.43±0.2325.43 + - 0.23
플라보노이드Flavonoid (mg/g)(mg / g) 7.41±0.827.41 ± 0.82 8.55±0.358.55 0.35 8.01±0.788.01 + - 0.78 8.25±0.668.25 + - 0.66 7.15±0.787.15 ± 0.78 2.16±0.352.16 ± 0.35
1-4) Reducing power 효능 분석1-4) Reducing power efficacy analysis
Reducing power 효능 분석은 FeCl3에 의한 산화적 반응 유도과정에 각 실시예의 조성물을 반응시켜 흡광도 값이 낮아지는 것을 이용하고 ascorbic acid의 효능과 비교분석하여 항산화 효과를 분석하였다.Reducing power efficacy analysis was based on the comparison of the effect of ascorbic acid with the lowering of the absorbance value by reacting the composition of each Example with the induction of oxidative reaction by FeCl 3 .
실시예의 각 조성물들을 200 mM 인산 나트륨 완충액(pH 6.6) 0.5 mL, 및 1 % 포타슘 페리시아나이드 0.5 mL과 혼합한 후 혼합물을 50 ℃에서 20 분동안 인큐베이션시키고, 이어서 10 % TCA 0.5 mL을 첨가하였다. 이를 650 g로 10 분 동안 원심분리시키고, 상층액 1 mL을 동일 부피의 증류수 및 0.1% 페릭 클로라이드 0.2 mL과 혼합하였다. 동일한 처리를 표준 아스코르브산 용액에 대하여 수행하고 흡광도를 700 nm에서 측정하였다. 환원력을 계산하고 아스코르브산 기준으로 나타내었다.Each of the compositions of the examples was mixed with 0.5 mL of 200 mM sodium phosphate buffer (pH 6.6), and 0.5 mL of 1% potassium ferricyanide, then the mixture was incubated at 50 DEG C for 20 minutes, followed by 0.5 mL of 10% TCA . It was centrifuged at 650 g for 10 minutes and 1 mL of supernatant was mixed with equal volume of distilled water and 0.2 mL of 0.1% ferric chloride. The same treatment was performed on standard ascorbic acid solution and the absorbance was measured at 700 nm. The reducing power was calculated and expressed in terms of ascorbic acid.
그 결과를 표 3에 나타내었다. 각 조성물의 Reducing power 효능은 비교예의 것에 상당히 현저히 높았다.The results are shown in Table 3. The Reducing power efficacy of each composition was significantly higher than that of the comparative example.
실시예4Example 4 실시예5Example 5 실시예6Example 6 실시예7Example 7 실시예8Example 8 비교예Comparative Example
환원력(ascorbic acid equivalent/g)The ascorbic acid equivalent (g) 28.12±1.5128.12 ± 1.51 27.23±0.3127.23 + - 0.31 22.67±0.5122.67 ± 0.51 26.35±0.7826.35 ± 0.78 22.36±0.9222.36 + - 0.92 13.34±0.5313.34 ± 0.53
1-5) Fe1-5) Fe 2+2+ chelating 활성 분석 chelating activity assay
Fe2+ chelating 활성 분석은 Fe2+-ferrozine complex에 의한 산화적 반응 유도과정에 실시예의 조성물을 반응시켜 흡광도 값이 낮아지는 것을 이용하여 항산화 효과를 측정하였다. The activity of Fe 2+ chelating activity was measured by reacting the composition of the present invention with the induction of the oxidative reaction by the Fe 2+ -ferrozine complex to lower the absorbance value.
바로 준비한 500 μM FeSO4 150 ㎕을 0.1 M Tris-HCl (pH 7.4) 170 μL, Tris-HCl 완충액 220 μL 및 각 실시예의 조성물을 혼합한 반응 혼합물에 첨가하였다. 반응 혼합물을 실온에서 5분 동안 인큐베이션시고, 0.25 % 1,10-phenanthroline (w/v) 10 μL을 첨가하였다. 흡광도를 510 nm에서 측정하였다. Fe2+ 킬레이팅 능력은 대조군에 대하여 다음의 식으로 계산하였다. 150 μl of the prepared 500 μM FeSO 4 was added to the reaction mixture in which 170 μL of 0.1 M Tris-HCl (pH 7.4), 220 μL of Tris-HCl buffer and the composition of each example were mixed. The reaction mixture was incubated at room temperature for 5 minutes and 10 μL of 0.25% 1,10-phenanthroline (w / v) was added. Absorbance was measured at 510 nm. The Fe 2+ chelating ability was calculated by the following equation for the control group.
Fe2+ chelating ability (%) = (Abscontrol without sample-Abssample)/Abscontrol without sample Х 100. Fe 2+ chelating ability (%) = (Abs control without sample - Abs sample ) / Abs control without sample Х 100.
비교분석을 위해 음성대조군은 vehicle (Tris-HCl buffer)을 처리하였고 양성대조군은 ascorbic acid를 처리하여 Fe2+ chelating 활성을 분석하였다.For comparative analysis, the negative control group was treated with vehicle (Tris-HCl buffer) and the positive control group was treated with ascorbic acid to analyze Fe 2+ chelating activity.
도 3은 실시예의 조성물의 Fe2+ 킬레이팅 에세이 분석 결과를 나타내는 그라프도이다. 양성대조군 ascorbic acid(AA)은 1 mg/ml 농도에서 Fe2+-ferrozine complex에 의한 산화적 반응을 39.08 ± 3.92% 억제시켰다. 각 실시예의 조성물은 100㎕에서 Fe2+-ferrozine complex에 의한 산화적 반응을 46.21±1.02% ~53.25±2.02%억제시킨 반면, 비교예의 것은 18.51±1.85% 억제시켰다.3 is a graph showing the results of Fe 2+ chelating assay analysis of the composition of the examples. Positive control ascorbic acid (AA) inhibited the oxidative response of Fe 2+ -ferrozine complex by 39.08 ± 3.92% at 1 mg / ml concentration. The compositions of each example inhibited the oxidative response of the Fe 2+ -ferrozine complex by 46.21 ± 1.02% to 53.25 ± 2.02% at 100 μl, while suppressing the comparative example by 18.51 ± 1.85%.
1-6) 아질산염 소거능 분석1-6) Nitrite scavenging ability analysis
아질산염 소거능 분석은 아질산염과 실시예의 조성물을 반응시켜 흡광도 값이 낮아지는 것을 이용하여 항산화 효과를 측정하였다. 비교분석을 위해 음성대조군은 vehicle (PBS)을 처리하였고 양성대조군은 ascorbic acid를 처리하여 아질산염 소거능을 분석하였다.The nitrite scavenging activity was measured by comparing the absorbance of the nitrite with the composition of the examples to determine the antioxidative effect. For comparative analysis, vehicle (PBS) was treated with negative control group and nitrite scavenging ability was treated with ascorbic acid in positive control group.
각 시료를 0.1 N HCl 용액(pH 1.2) 및 pH 3.0, pH 5.0 용액으로 처리한 후 1 mM NaNO2 용액을 첨가하였다. 혼합물을 37℃에서 1 시간 동안 인큐베이션시켰다. 2 % 아세트산 및 Griess 시약을 첨가한 후 실온에서 15 분 동안 인큐베이션시켰다. 520 nm에서 혼합물의 흡광도를 측정하였다. Each sample was treated with 0.1 N HCl solution (pH 1.2), pH 3.0 and pH 5.0 solution, and 1 mM NaNO 2 solution was added. The mixture was incubated at 37 [deg.] C for 1 hour. 2% acetic acid and Griess reagent were added and incubated at room temperature for 15 minutes. The absorbance of the mixture was measured at 520 nm.
도 4는 실시예 조성물의 아질산 소거능 분석 결과를 나타내는 그라프도이다(pH 1.2). 아질산염 억제(%) = [1 - (Abssample/Abscontrol without sample)] x 100. 콘트롤, 음성 대조군으로서 PBS (vehicle) 처리군; AA, 양성 대조군으로서 ascorbic acid (1 mg/ml) 처리군;100 ㎍, 시료군으로서 조성물 100㎍.4 is a graph (pH 1.2) showing the nitrite scavenging activity of the composition of Example. Nitrite inhibition (%) = [1 - (Abs sample / Abs control without sample )] x 100. Control, group treated with PBS as a negative control group; AA, a group treated with ascorbic acid (1 mg / ml) as a positive control; 100 ㎍, 100 쨉 g of a composition as a sample group.
양성대조군 ascorbic acid(AA)은 1 mg/ml 농도에서 아질산염을 pH 1.2 조건에서 91.0 ± 3.12% 억제시켰다. 각 실시예의 조성물은 아질산염을 pH 1.2 조건에서 56.73±1.12%(실시예 4) 내지 61.32±1.09%(실시예 7) 억제시키고, 비교예의 것은 20.51±0.76%억제시켰다. Positive control ascorbic acid (AA) inhibited nitrite at a concentration of 1 mg / ml by 91.0 ± 3.12% at pH 1.2. The composition of each example inhibited nitrite at 56.73 ± 1.12% (Example 4) to 61.32 ± 1.09% (Example 7) at pH 1.2 and 20.51 ± 0.76% inhibition of the comparative example.
시험예 2: 항균 활성 시험 Test Example 2: Antimicrobial activity test
실시예 4~8에 따른 조성물의 미생물에 대한 방부력 및 살균력에 대하여 disc paper test를 실시하여 시험하였다. The antimicrobial and antimicrobial properties of the compositions according to Examples 4 to 8 were tested by disc paper test.
시험균주를 petri dish 에 분주하여 유리막대를 사용하여 배지 전체에 넓게 도말한 후 직경 5㎜의 paper disc를 그 위에 올려 놓았다. 그리고 각 실시예의 조성물 30㎕를 paper disc 위에 넣었다. 30 ℃에서 하룻밤 배양한 후 Inhibition zone을 확인하여 항균성을 알아보았다. 그 결과를 다음의 표 4에 나타냈다.The test strain was dispensed into a petri dish, spread over the entire medium using a glass rod, and then placed on a paper disc having a diameter of 5 mm. Then, 30 쨉 l of the composition of each example was placed on a paper disc. After overnight incubation at 30 ° C, the inhibition zone was checked for antimicrobial activity. The results are shown in Table 4 below.
시험 균주Test strain Inhibition zone(d) : ㎝Inhibition zone (d): cm
Ex4Ex4 Ex5Ex5 Ex6Ex6 Ex7Ex7 Ex8Ex8 Comp. Ex.Comp. Ex.
Staphylococcus aureus ATCC 10537Staphylococcus aureus ATCC 10537 2.52.5 2.42.4 2.62.6 2.82.8 2.52.5 1.01.0
Staphylococcus aureus ATCC 256EStaphylococcus aureus ATCC 256E 2.62.6 2.52.5 2.52.5 3.03.0 2.52.5 1.51.5
Salmonella typhimurium KCTC 1925Salmonella typhimurium KCTC 1925 2.82.8 2.92.9 2.62.6 3.13.1 2.72.7 1.81.8
Candida albicans ATCC 10231Candida albicans ATCC 10231 2.42.4 2.82.8 2.82.8 3.23.2 2.52.5 2.02.0
위의 시험결과로부터 알 수 있는 바와 같이, 본원 발명에 따른 조성물은 정도의 차이가 있으나 무좀균 등의 세균에 대한 우수한 항균작용을 가지므로 이를 요하는 용도의 화장용 제품이나 무좀 치료제로 사용할 수 있다.As can be seen from the above test results, the composition according to the present invention has excellent antimicrobial activity against bacteria such as fungi such as aphthous fungus, though it has a difference in degree. Therefore, it can be used as a cosmetic product or a treatment for athlete's foot.
시험예 3: 곰팡이의 생육저해활성 측정Test Example 3: Measurement of growth inhibitory activity of fungi
곰팡이균, 트리코피톤 루브럼(Trichophyton rubrum , KCTC 6345), 마이코스포럼 오더위니(Micosporum audouinii, KCTC 6346), 트리코피톤 페러기네움(Trichophyton ferrugineum, KCTC6351), 에피더모피톤 플로코섬(Epidermophyton floccosum, KCTC 6586), 트리코피톤 멘타그로피테스(Trichophyton mentagrophytes, KCTC 6077) 5종을 대상으로 생육 저해 활성에 대하여 시험하였다. 곰팡이 생육저해활성은 여지확산법(Paper disc diffusion method)으로 검정하였다. 각 균주를 사보라우드 한천(Sabouraud's agar) 배지에 접종한 후 각 조성물(실시예 4~8, 처리농도 100 ㎍)을 직접 paper disc에 처리하였다. 여지를 각 균이 접종된 상기 배지에 올려놓고 28℃에서 5일간 호기배양 한 후, 여지 주위에 형성된 생육저해환(clear zone)의 크기를 보고 항균 활성을 체크하고, 그 결과를 표 5에 나타내었다.( Eg , Trichophyton rubrum , KCTC 6345), Micosporum audouinii (KCTC 6346), Trichophyton ferrugineum (KCTC6351), Epidermophyton floccosum , KCTC 6586), and Trichophyton mentagrophytes (KCTC 6077) were tested for growth inhibitory activity. Fungal growth inhibitory activity was assayed by the paper disc diffusion method. Each strain was inoculated into a Sabouraud's agar medium and treated with each composition (Examples 4 to 8, treatment concentration 100)) directly on a paper disc. The leaves were placed on the culture medium inoculated with each bacterium and cultured for 5 days at 28 ° C. The size of the clear zone formed around the foliage was measured to check the antimicrobial activity. The results are shown in Table 5 .
시험 균주Test strain Inhibition zone(d) : ㎝Inhibition zone (d): cm
Ex4Ex4 Ex5Ex5 Ex6Ex6 Ex7Ex7 Ex8Ex8 Comp. Ex.Comp. Ex.
Trichophyton rubrumTrichophyton rubrum 3.03.0 3.23.2 3.33.3 3.83.8 3.53.5 0.50.5
Micosporum audouiniiMicosporum audouinii 3.23.2 3.33.3 3.13.1 3.53.5 2.82.8 0.50.5
Trichophyton ferrugineumTrichophyton ferrugineum 2.52.5 3.03.0 2.82.8 3.33.3 2.52.5 0.80.8
Epidermophyton floccosumEpidermophyton floccosum 2.52.5 3.53.5 3.03.0 3.03.0 2.52.5 1.01.0
Trichophyton mentagrophytesTrichophyton mentagrophytes 3.03.0 3.53.5 3.03.0 3.53.5 3.03.0 0.80.8
실시예의 조성물에 의한 생육저해환의 크기는 2.5 cm 이상으로 나타났으며, 뛰어난 곰팡이 생육저해활성을 가지는 것으로 나타났다. 이러한 항균활성은 나머지 진균들에서도 비슷한 양상을 보였다.The size of the growth inhibition ring by the composition of the examples was 2.5 cm or more and showed excellent fungicidal activity. These antimicrobial activities were similar in other fungi.
시험예 4: 피부자극시험Test Example 4: Skin irritation test
본 발명의 실시예에 따른 각 조성물의 실험동물에 대한 자극성 정도를 알아보고자 피부자극 실험을 수행하였다. 실험동물로는 체중 2.3-2.7 kg의 3-4개월령의 뉴질랜드 white rabbit 8 마리를 사용하였다. 먼저, 실험 동물들을 입수후 1주일간 동물실에서 순화시키고 순화기간 중 일반 상태를 관찰하여 건강한 동물만을 시험에 사용하였다. 토끼는 시험물질 적용 24시간 전에 제모를 실시하여 처치 구획 및 대조 구획으로 구분한 다음 시험동물 한 마리당 시험물질 0.5 ml씩 투여부위에 1회 도포하고, 무처치 대조구획에는 멸균 생리 식염수를 동량 도포하였다. 부착 후 고형 재질의 박지로 덮고 테이프를 사용하여 고정한 후 일정시간 적용시켰다. 적용시간 종료후에는 생리식염수를 이용해 도포부를 가볍게 세정해 주었다. 시험물질 투여후 일주일간 매일 외관, 사료 및 음수 소비 상태와 임상증상 등에 대하여 관찰하고, 적용후 7일째에 국소마취제(리도카인, 광명약품)를 귀정맥을 통해 주입하여 안락사시킨 후 부검하여 이상유무를 육안으로 관찰하였다.Skin irritation experiments were conducted to examine the degree of irritation of each composition according to the present invention to experimental animals. Eighteen New Zealand white rabbits weighing 2.3 to 2.7 kg were used as experimental animals. First, experimental animals were refined in an animal room for one week after their intake, and normal animals were observed during the refinement period and only healthy animals were used for the test. The rabbits were divided into treatment compartments and control compartments 24 hours before application of the test substance, and then 0.5 ml of the test substance per test animal was applied once to the administration site, and sterilized physiological saline was applied to the untreated control compartment in the same amount . After attaching, it was covered with a sheet of solid material, fixed with a tape, and applied for a certain period of time. After the application time, the application portion was gently rinsed with physiological saline. On the seventh day after application, local anesthetics (lidocaine, Gwangmyeong drug) were injected through the ear vein and euthanized, followed by autopsy. And observed with naked eyes.
피부반응의 평가는 "의약품 등의 독성시험기준"을 이용하여 24 시간과 72 시간에 대하여 판정하였다. 또한 피부에 대한 자극성의 정도 판정은 일반적으로 많이 이용되는 Draize의 P.I.I.(Primary Irritation Index)의 산출방법에 따랐다. 시험결과 시험물질 도포부위의 홍반과 가피형성 및 부종 등의 자극성은 인정되지 않았으며, Draize의 P.I.I에 의한 피부1차 자극율은 "0"으로 평가되었다.Skin reactions were evaluated for 24 hours and 72 hours using the " Standards for Toxicological Testing of Drugs and the like ". The degree of irritation to the skin was also calculated according to the method of calculating the Draize's Primary Irritation Index (P.I.I.), which is commonly used. As a result of the test, irritation such as erythema, scar formation and edema of the test substance application site was not recognized, and the primary irritation rate of skin by P. I. Draize was evaluated as "0".
시험예 5: 급성 독성 시험Test Example 5: Acute Toxicity Test
실시예의 조성물에 대하여 급성 독성 실험을 수행하고 그 독성유무를 관찰하였다. 실험용동물은 4, 5주령의 체중 105의 수컷과 95의 암컷의 SD계 래트 60 마리를 사용하였고 각 실시예의 조성물과 음성대조군으로서 증류수를 사용하여 시험하였다. 먼저, 상기 래트들을 온도 22℃, 상대습도 53% 및 형광등 조명(09:00 점등-18:00 소등)의 명암사이클, 150-300 Lux의 조도 조건을 갖춘 실험실 사육 상자에서 약 1주일 정도의 기간에 걸쳐 순화시킨 다음, 건강한 동물들만을 선택하여 평균 체중이 일치하도록 각 군으로 나누고 일일 1회 20ml/kg의 양으로 14일 동안 강제 경구투여한 다음, 일반상태의 변화, 중독증상, 운동성, 외관, 자율신경, 체중변화 및 사망동물의 유무에 관하여 점검하였다.The compositions of the examples were subjected to acute toxicity studies and their toxicity was observed. As experimental animals, male and female SD rats of 105 weight and 105 weight, respectively, were used and tested by using the compositions of the respective examples and distilled water as a negative control. First, the rats were incubated in a laboratory incubation box with a temperature of 22 ° C, a relative humidity of 53% and a fluorescent light (09:00 lit-18: 00 off) contrast cycle and a light intensity of 150-300 Lux for about a week , And then healthy animals were selected and divided into groups so that the average body weight was matched. The animals were orally administered at a dose of 20 ml / kg once a day for 14 days, and then the changes in general condition, poisoning symptoms, , Autonomic nerves, weight change, and presence of dead animals.
실험 결과에 의하면, 실험기간 동안 체중에 있어서 5% 이내의 변화를 보였으나 유의성은 없었고, 시료의 양을 시험동물에 투여가능한 최대량인 kg당 20ml의 최고 농도를 선정하였음에도 사망동물이 관찰되지 않아 개략의 치사량 산출은 불가하였으므로 LD50은 20ml/kg B.W. 이상인 것으로 나타났고, 특이한 일반증상이나 부검시 특이한 병변이 관찰되지 않았으므로 이를 종합적으로 판단해보면 상기 조성물은 독성이 없는 것으로 판명되었다.According to the experimental results, there was no significant difference in the body weight during the experimental period, but there was no significant difference. The highest concentration of 20 ml per kg, which is the maximum amount of sample to be administered to the test animal, was selected, LD 50 was more than 20 ml / kg BW because of the inability to calculate the lethal dose, and it was found that the composition was not toxic when it was judged according to the general symptoms or the specific lesion upon autopsy.
이상에서 설명한 본 발명은 전술한 실시예 및 첨부한 도면에 의해 한정되지 않으며, 본 발명의 기술적 사상을 벗어나지 않는 범위 내에서 치환, 변형 및 변환이 가능하다는 것을 본 발명이 속하는 기술 분야에서, 통상의 지식을 가진 자에게 있어 명백할 것이다.It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit or scope of the invention as defined in the appended claims. It will be clear to those who have knowledge.
본 발명은 무좀 예방 또는 개선용 조성물은 천연 오일을 주성분으로 하고 독성이나 피부자극 등의 부작용이 적을 뿐만 아니라 피부보호, 항산화 및 항균 작용을 동시에 나타내므로 무좀의 예방 및 개선을 위한 화장품 또는 제약 조성물로서 관련 제품생산에 있어 유용성이 있다.The present invention relates to a cosmetic or pharmaceutical composition for prevention and improvement of athlete's foot since the composition for prevention or improvement of athlete's foot is natural oil as a main component and exhibits skin protection, antioxidant and antimicrobial action simultaneously as well as less side effects such as toxicity and skin irritation It is useful in the production of related products.

Claims (4)

  1. 티트리 오일 50 ~ 75 중량%, 아보카도 오일 10 ~ 30 중량%, 방풍뿌리 추출물 또는 편백 추출물 3 ~ 15 중량%, 호장근 추출물 3 ~ 15 중량%, 조릿대 추출액 1 ~ 10 중량%, 비타민 E 아세테이트 0.5 ~ 2 중량%, 폴리소르베이트(20) 0.5 ~ 2 중량%, 벤질알코올 0.01 ~ 0.05 중량% 및 티몰(thymol) 0.01 ~ 0.05 중량%를 포함하는 것을 특징으로 하는 무좀 예방 또는 개선용 외용제 조성물.Vitamin E acetate 0.5 to 50% by weight, tea tree oil 50 to 75% by weight, avocado oil 10 to 30% by weight, safflower root extract or curd extract 3-15% by weight, Wherein the composition comprises 0.5 to 2% by weight of polysorbate 20, 0.5 to 2% by weight of polysorbate 20, 0.01 to 0.05% by weight of benzyl alcohol and 0.01 to 0.05% by weight of thymol.
  2. 청구항 1에 있어서,The method according to claim 1,
    상기 티트리 오일, 아보카도 오일을 포함하는 식물성 오일은 잎이나 과실 또는 열매를 식물을 압착하여 얻거나 또는 원료에 1:2 내지 1:20 중량 비율로 추출용매를 가하여 환류냉각장치에 넣고 2~3 시간 동안 가열 증류시킨 후 냉각시킨 후, 냉각시킨 추출물을 5~7시간 동안 여과하여 추출물을 개별적으로 제조된 것이고,The vegetable oil containing the tea tree oil or the avocado oil is obtained by squeezing a leaf, a fruit or a fruit into plants, or an extraction solvent is added to the raw material in a weight ratio of 1: 2 to 1:20, After cooling, the extract was filtered for 5 to 7 hours to obtain an extract.
    편백은 잎 또는 줄기, 가지 등에 추출용매를 가하여 열수추출, 냉침 또는 온침 추출할 수 있다. 이 경우 편백에 대하여 추출용매를 중량비로 2 내지 20배를 가하여 혼합한 후 70 내지 125℃에서 2 내지 24시간 동안 추출하고, 여과하고 농축하여 추출물을 얻은 것이며,Leaves, stems, branches and the like can be extracted by hot water extraction, cold-watering or warm-up extraction. In this case, the extraction solvent is mixed with the extraction solvent in a weight ratio of 2 to 20 times, and the mixture is extracted at 70 to 125 ° C for 2 to 24 hours, filtered and concentrated to obtain an extract.
    상기 조릿대, 호장근 및 방풍 뿌리는 깨끗이 세척하여 건조하여 세절한 다음 원료 중량의 5배 내지 10 배의 추출용매를 더하여 고압멸균솥에 넣고 65 ~ 125℃의 온도에서 2 내지 6시간, 바람직하게는 5시간 동안 가열시켜 추출하여 여과하고 농축하여 얻은 것을 특징으로 하는 무좀 예방 또는 개선용 외용제 조성물.The bamboo shoots, bamboo shoots, and windshield roots are thoroughly cleaned, dried, and then added with an extraction solvent 5 to 10 times the weight of the raw materials. The resulting mixture is placed in a autoclave autoclave and heated at 65 to 125 ° C for 2 to 6 hours, The mixture is heated for 5 hours for extraction, filtered, and concentrated to obtain a composition for external application for preventing or improving athlete's foot.
  3. 청구항 1에 있어서,The method according to claim 1,
    상기 추출용매는 정제수, 탄소수 1 내지 4의 저급 알코올, 다가 알코올 또는 이들의 혼합물로부터 선택된 적어도 어느 하나인 것을 하는 무좀 예방 또는 개선용 외용제 조성물.Wherein the extraction solvent is at least one selected from the group consisting of purified water, a lower alcohol having 1 to 4 carbon atoms, a polyhydric alcohol, or a mixture thereof.
  4. 청구항 1에 있어서, 항산화 작용, 항균작용 또는 피보 보호작용을 갖는 것을 특징으로 하는 무좀 예방 또는 개선용 외용제 조성물.The composition for external use for the prevention or improvement of athlete's foot according to claim 1, which has an antioxidative action, an antibacterial action or a pervative protective action.
PCT/KR2018/007695 2017-07-06 2018-07-06 Composition for preventing and ameliorating athlete's foot WO2019009663A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2017-0086138 2017-07-06
KR1020170086138A KR101869763B1 (en) 2017-07-06 2017-07-06 Composition for preventing and curing dermatophytosis

Publications (1)

Publication Number Publication Date
WO2019009663A1 true WO2019009663A1 (en) 2019-01-10

Family

ID=62806528

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/007695 WO2019009663A1 (en) 2017-07-06 2018-07-06 Composition for preventing and ameliorating athlete's foot

Country Status (2)

Country Link
KR (1) KR101869763B1 (en)
WO (1) WO2019009663A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101869763B1 (en) * 2017-07-06 2018-06-21 최병규 Composition for preventing and curing dermatophytosis
KR20230114445A (en) 2022-01-25 2023-08-01 이지영 Composition for preventing and improving athlete's foot

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040072769A (en) * 2003-02-11 2004-08-19 학교법인 신천학원 Bathroom soap comprising plum extracts and extracting method thereof
KR20070079497A (en) * 2006-02-02 2007-08-07 주식회사 에스티씨나라 External composition for improvement of skin containing herbal extracts
KR20070087147A (en) * 2007-07-18 2007-08-27 가부시키가이샤 호오도 Skin protecting compositions
KR20100061091A (en) * 2008-11-28 2010-06-07 (주)아모레퍼시픽 A cleanser composition containing natural anti-bacterial components
KR20110116593A (en) * 2010-04-19 2011-10-26 주식회사 바이오에프디엔씨 A skin external composition having improving ability for atopy dermatitis
KR101869763B1 (en) * 2017-07-06 2018-06-21 최병규 Composition for preventing and curing dermatophytosis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101117564B1 (en) 2009-06-12 2012-03-13 주식회사 코리아나화장품 Scrub cosmetic composition comprising salt and/or sugar

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040072769A (en) * 2003-02-11 2004-08-19 학교법인 신천학원 Bathroom soap comprising plum extracts and extracting method thereof
KR20070079497A (en) * 2006-02-02 2007-08-07 주식회사 에스티씨나라 External composition for improvement of skin containing herbal extracts
KR20070087147A (en) * 2007-07-18 2007-08-27 가부시키가이샤 호오도 Skin protecting compositions
KR20100061091A (en) * 2008-11-28 2010-06-07 (주)아모레퍼시픽 A cleanser composition containing natural anti-bacterial components
KR20110116593A (en) * 2010-04-19 2011-10-26 주식회사 바이오에프디엔씨 A skin external composition having improving ability for atopy dermatitis
KR101869763B1 (en) * 2017-07-06 2018-06-21 최병규 Composition for preventing and curing dermatophytosis

Also Published As

Publication number Publication date
KR101869763B1 (en) 2018-06-21

Similar Documents

Publication Publication Date Title
KR101425031B1 (en) Cosmetic composition for anti-irritation and skin moisturization containing Citrus junos Siebold seed oil and Mangifera Indica seed oil
JP5137457B2 (en) Stem cell growth factor expression increase inhibitor
KR101073678B1 (en) Shampoo composition using medical herbs and manufacturing method thereof
KR101458887B1 (en) Composition for improving skin condition containing the complex extracts of Pachyrhizus erosus, Brassica oleracea L. var botrytis, Malva sinensis var. mauritiana Mill. and Cetraria islandica
KR20130015339A (en) Cream composition for treating acne
KR101397160B1 (en) Cosmetic compositon for skin-irritation alleviation with Inula britannica var. chinensis, Cynanchi Radix and Lysimachia foenum-graecum Hance
KR101332215B1 (en) Cosmetic composition containing fermentated complex of extracts with cryptomeria japonica and nelumbo nucifera for acne improvement and enhancing immune system
KR101142541B1 (en) Anti-wrinkle cosmetic composition containing oriental herb extract treated by enzyme and its extraction method
WO2019009663A1 (en) Composition for preventing and ameliorating athlete&#39;s foot
KR100668290B1 (en) Cosmeceutical compositions comprising a Rumex acetosella L. extract and/or a Rheum coreanum extract with improvement effect of atopic dermatitis
KR101142977B1 (en) Cosmetic Composition Comprising Opuntia Five Element Tea Mixed Extract For Improving Atopic skin And Manufacturing Method Thereof And Cosmetic Material Containing The Same
KR101047612B1 (en) Cosmetic composition for reducing or treating acne and acne rash
US20200078290A1 (en) Cosmetic Composition Comprising Extract Of Medicinal Herbs As Active Ingredient
KR20190093283A (en) Cosmetic composition composed of including extracts of drynaria fortunei and cosmetics using the same
KR101459742B1 (en) Cosmetic composition for improving acne containing extracts of natural substance
KR101252560B1 (en) Cosmetic composition containing extracts of Impatiens balsamina L. for controlling anti-acne or anti-comedone
WO2020059906A1 (en) Composition comprising extract of cinnamomum aromaticum, lonicera japonica, elsholtzia ciliate, schisandra chinensis, arctium lappa, and paeonia suffruticosa for prevention or treatment of skin aging or dermatitis and method using same
KR102400090B1 (en) Cosmetic Composition for Reducing Skin Wrinkle
KR20090075950A (en) Therapeutical compositions for obstinate atopic dermatitis
KR20180017974A (en) Cosmetic composition for preventing or treating acne comprising combined herbal extracts
KR101521083B1 (en) External agent for skin comprising extract of cudrania tricuspidata
KR20140145324A (en) Fermented seed complex derived from mixed seed extract, method for preparing of the fermented seed complex, and cosmetic composition containing the fermented seed complex
KR101769123B1 (en) Cosmetic composition containing natural complex extract for improving atopic dermatitis
KR102628844B1 (en) Cosmetic composition for anti-oxidation, skin whitening and anti-wrinkle containing a mixed fermentation extracts of Wisteria floribunda flowers, Aralia elata flowers, Camellia japonica leafs and Camellia japonica flowers as effective component
KR20190005461A (en) Composition for preventing and curing dermatophytosis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18828661

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18828661

Country of ref document: EP

Kind code of ref document: A1